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ABSTRACT 
In Newfoundland and Labrador (NL) accessing fertility services is challenging for 
many residents, as a result of lack of service availability within the province, 
geographical distance from location of services, and out-of-pocket expenses for both 
treatment and travel. The purpose of this study was to explore the challenges experienced 
by fertility patients in NL and how these challenges affect treatment. Semi-structured, in-
depth interviews were conducted with female patients across Newfoundland and service 
providers from NL Fertility Services to gather the perspectives of both patients and 
providers. We developed a conceptual framework that considers patient group, 
therapeutic goal, and barriers when determining treatment impacts. We found that for 
heterosexual women (in couples) looking to become pregnant, the most commonly cited 
barriers were costs, including financial, opportunity, and emotional, geography, lack of 
service availability, nature of services, physical environment, partner separation, and 
social stigma. We also found that these factors created patient and provider-driven 
impacts on treatment. 
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1.0 Introduction 
1.1 Background 
Accessing fertility services is challenging for many residents of Newfoundland 
and Labrador (NL). The province is geographically vast and has only one fertility clinic 
located in the capital city of St. John’s, forcing patients from outside St. John’s to travel 
great distances in order to access services. NL’s provincial health insurance, the Medical 
Care Plan (MCP), covers limited fertility services. These services are expensive and 
multiple rounds of treatment may be required. Furthermore, the province has a small and 
dispersed population with few residents accessing fertility services, which means that the 
full range of fertility services are not available locally and patients must often travel to 
other provinces to receive some treatments. Patients must pay out-of-pocket expenses for 
their travel to the clinic and for their fertility drugs and treatments. These costs often 
create financial strain for patients and their families. 
This study provides NL-specific information about the financial and geographic 
challenges faced by patients accessing fertility services in the province and how these 
challenges affect treatment options. The study was done in collaboration with 
Newfoundland and Labrador Fertility Services (NLFS), which is a division of the Eastern 
Regional Health Authority responsible for providing reproductive care. The Eastern 
Regional Health Authority provides health care services to the eastern region of 
Newfoundland.   
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1.2 Research Questions and Objectives 
What are the challenges experienced by patients in NL when accessing fertility 
services? How do these challenges affect the provision of fertility services?  
The objectives of the study are: 
1. To describe the challenges experienced by patients seeking infertility treatment. 
2. To explore whether there are differences in the challenges experienced by patients 
seeking infertility treatment who live in St. John’s or surrounding areas (within 
about 50 km of NLFS) compared to those who live in other areas of the province 
(farther than 50 km away).  
3. To explore how these challenges impact decisions made by patients, including 
treatment and travel options. 
4. To determine how the challenges patients face affect the provision of care from 
the perspective of service providers. 
In this study, we expect that: 
1. There will be financial and geographical challenges affecting patients’ access to 
fertility services and patients travelling from farther than 50 km away will face 
geographical barriers that exacerbate financial challenges. 
2. Patients’ financial and geographical situations will affect treatment decisions from 
both the patient and service provider perspectives. 
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1.3 Rationale 
As of 2010, about 16% of Canadian couples experienced infertility (Bushnik, 
Cook, Yuzpe, Tough, & Collins, 2012); this rate is more than double the 1984 rate of 
5.4% (Balakrishnan & Fernando, 1993) and about twice as high as the 2006 global rate of 
9% (Boivin, Bunting, Collins, & Nygren, 2007). With infertility rates on the rise in 
Canada, research related to infertility and fertility services is increasingly important.  
Despite increasing need, fertility services may not be accessible to patients in NL. 
They are a highly specialized service, similar to orthodontics, prosthetics, and audiology, 
and may not be considered medically necessary under the Canada Health Act; however, 
they are critical for the well-being, especially emotional health, of residents (Domar & 
Gordon, 2011; Holley et al., 2015; Newton, Sherrard, & Glavac, 1999). According to care 
providers at NLFS, the challenges faced by patients accessing these services include, but 
are not limited to, the lack of service availability within the province, geographical 
distance from location of services, and out-of-pocket expenses for both treatment and 
travel (T. O’Grady & H. Rees, personal communication, May 25, 2015). Fertility services 
are arguably more difficult to access in NL than most other provinces; this topic has not 
yet been examined in the literature. 
The status of fertility services in NL presents unique challenges for patients 
wishing to have a child through the use of these services. This study explored the 
experiences of patients and service providers in an effort to better understand the 
challenges faced by patients accessing fertility services in NL and how these challenges 
influence treatment decisions. It provides NL-based data on how health service access 
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and costs affect care and decision-making. We hope to make policy recommendations 
that will help improve access to these services for patients from NL.   
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2.0 Literature Review 
Since the birth of Louise Brown in 1978, the first baby born through in vitro 
fertilization (IVF), there have been hundreds of books and thousands of articles published 
about infertility and assisted reproductive technologies. However, the scope of this 
literature review will be relatively narrow, covering topics that are most relevant to this 
study - the barriers to accessing fertility services in NL. The chapter will first overview 
infertility, as this condition establishes the need for fertility services. It will then address 
assisted human reproduction and its regulation in Canada, as well as health care 
management and funding, in order to give context to the NL case. Finally, the chapter 
will examine some issues related to health service access, specifically cost and 
geography, generalizing and applying these ideas to the NL case with fertility services.   
2.1 Infertility 
The definition of infertility varies from study to study. The World Health 
Organization defines infertility as “a disease of the reproductive system defined by the 
failure to achieve a clinical pregnancy [(diagnosed by ultrasonographic visualization of 
one or more gestational sacs or definitive clinical signs of pregnancy)] after 12 months or 
more of regular unprotected sexual intercourse” (Zegers-Hochschild et al., 2009, p. 
1522). Gurunath, Pandian, Anderson, and Bhattacharya (2011) reviewed the literature to 
determine how infertility is commonly defined in prevalence studies and to suggest a 
consolidated and relevant definition. They found the greatest conceptual differences 
between demographic and epidemiological definitions. Demographic infertility is defined 
as “childlessness in a population of women of reproductive age”, while epidemiological 
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infertility specified an amount of time without achieving pregnancy in a population of 
women generally having unprotected sex (Gurunath et al., 2011, p. 575). They concluded 
that a uniform definition of infertility should be clinically relevant and include both time 
spent trying to achieve pregnancy and age of women (Gurunath et al., 2011).  
Due to the variation in the definition of infertility, the prevalence also varies 
between studies based on how infertility has been defined (Table 2.1). While all of the 
following definitions specify a time period (i.e., 12 months) and the absence of 
contraception, they vary in terms of reporting sexual intercourse, intention to become 
pregnant, and partner surgical sterilization. 
Table 2.1 
 
Canadian Infertility Prevalence Studies with Definitions and Corresponding Infertility 
Rates 
Study Definition Infertility Rate (%) 
Bushnik et al. (2012) Couples who did not use birth 
control in the preceding 12 months 
15.7 
Couples who did not use birth 
control and reported having sexual 
intercourse in the preceding 12 
months 
14.0 
Couples who did not use birth 
control and reported having sexual 
intercourse in the preceding 12 
months with the purpose of 
attempting to become pregnant 
11.5 
Collins et al. (1997) A woman that did not use 
contraception in the past 12 months, 
that neither she nor her partner were 
surgically sterilized, and that she was 
not pregnant in the past 12 months  
8.5 
Balakrishnan and Fernando 
(1993) 
Women in union who did not use 
birth control in the preceding 12 
months 
5.4 
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Using three different definitions of infertility, Bushnik et al. (2012) used 
infertility data from the 2009-2010 Canadian Community Health Survey to estimate 
infertility amongst couples where the female partner was between 18 and 44 years old. 
Not surprisingly, the results showed different infertility rates; 15.7% using the first 
definition, 14% using the second, and 11.5% using the third definition, with a significant 
difference only between the first and third definitions (Bushnik et al., 2012). Older 
studies by Balakrishnan and Fernando (1993) and Collins, Feeny, and Gunby (1997), 
used similar definitions to the first definition used by Bushnik et al. The variation in 
prevalence based on definition demonstrates the issues that arise when surveys fail to 
thoroughly report information. Balakrishnan and Fernando (1993) and Collins et al. 
(1997) did not report on sexual activity and intent to become pregnant. This means that 
the only comparable infertility rates are those for patients who did not become pregnant 
while not using birth control and did not report sexual activity or intent to become 
pregnant in the preceding 12 months. The Bushnik et al. study reiterates the problems 
associated with the lack of universally accepted infertility definition, as it used three 
different definitions of infertility, which produced three different infertility rates. Despite 
the varying definitions and rates, the prevalence of infertility has clearly increased over 
the last 20 years. 
The rising prevalence of infertility is impacted by the variety of causes of the 
condition. Infertility may be the result of a single factor or multiple factors, either in the 
male or female partner. Blundell (2007) claims that female, male, and idiopathic causes 
are responsible for 45%, 30%, and 25% of infertility cases, respectively. In women, 
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infertility may result from various factors including age, blocked fallopian tubes, 
irregular menstruation, or uterine polyps and fibroids (Blundell, 2007; Soto & 
Copperman, 2011). In men, infertility may be linked to sperm morphology, motility, and 
concentration (Guzick et al., 2001). In both sexes, infertility may be related to stress, 
smoking, alcohol consumption, sexually transmitted infections, as well as being under or 
over-weight (Grodstein, Goldman, & Cramer, 1993; Negro-Vilar, 1993; Ochsendorf, 
2008; Soto & Copperman, 2011). The causes of infertility are approached here from a 
biomedical perspective; however, infertility and its causes should be considered from a 
social constructivist perspective as well. 
Although infertility is most commonly defined and recognized as a medical 
condition, it can be argued that it is also a social condition, as women often feel societal 
pressure to be mothers (Marwah, Venkatachalam, & Nayak, 2014; Montpetit, Scala, & 
Fortier, 2004; Scala, Montpetit, & Fortier, 2005). This pressure is derived from the social 
construction of gender and gender roles (Staikou, 2014). For women, motherhood is a 
role perpetuated by social, cultural, and patriarchal values (Staikou, 2014). Women may 
be ostracized because of their inability to conceive (Marwah et al., 2014). Interviews with 
Indian women found that women experienced social exclusion for not being able to have 
children, even if it was the result of their husband’s infertility (Marwah et al., 2014). In 
an American study, questionnaires used to assess perceived infertility-related stress 
among male and female patients found that women experienced greater stress than men 
from infertility-related social concerns, sexual concerns, and the need for parenthood 
(Newton et al., 1999). This need for parenthood also demonstrates the constructed ideals 
 9 
surrounding parenting, as society defines parenthood in terms of the “biological parent” 
and assigns value to individuals based on their ability to have biological children. 
Biological parents are considered more legitimate than step or adoptive parents (Fisher, 
2003). 
Infertility is a complex condition impacted by biological, environmental, and 
social factors. Treatment to help patients overcome this condition is necessary for both 
biological and social reasons.  
2.2 Assisted Human Reproduction 
With the rise in reported infertility rates, there has also been an increase in the use 
of assisted reproductive technologies in Canada (Bushnik et al., 2012). The World Health 
Organization defines Assisted Reproductive Technology (ART) as follows: 
All treatments or procedures that include the in vitro handling of both human 
oocytes and sperm or of embryos for the purpose of establishing a pregnancy. 
This includes, but is not limited to, in vitro fertilization and embryo transfer, 
gamete intrafallopian transfer, zygote intrafallopian transfer, tubal embryo 
transfer, gamete and embryo cryopreservation [for future use], oocyte and embryo 
donation, and gestational surrogacy. ART does not include [intrauterine 
insemination] using sperm from either a woman’s partner or a sperm donor. 
(Zegers-Hochschild et al., 2009, p. 1521)  
 
In this thesis the term “fertility services” is used to refer to a broader range of 
services, including ARTs, intrauterine insemination (IUI), diagnostic services, as well as 
pre and post ART patient management.  
2.2.1 Fertility services.  
Some of the more common fertility services include IUI, IVF, intracytoplasmic 
sperm injection (ICSI), and cryopreservation. IUI is the injection of sperm into a 
woman’s uterus through the vagina (Boyajian et al., 2014). The sperm is washed and a 
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more concentrated sample is obtained prior to injection in order to optimize the chances 
of achieving pregnancy (Veltman-Verhulst, Hughes, Ayeleke, & Cohlen, 2016). Patients 
may use this treatment if they are struggling to become pregnant on their own or if they 
are using purchased or donated sperm. Cochrane reviews reported that there is evidence 
of moderate quality demonstrating that there is no difference in the live birth rate of 
women who have IUI versus women who use timed intercourse1 (Veltman-Verhulst et 
al., 2016). 
Oftentimes, women undergoing IUI will also be taking fertility drugs to stimulate 
follicular growth. Although service providers err on the side of caution, stimulating 
follicular growth may mean fertilization of multiple ova, which can result in a multiple 
pregnancy. Multiple pregnancies can have serious consequences for both mother and 
child, with increased risk of complications, morbidity, and mortality (Brambati, Tului, 
Camurri, & Guercilena, 2004; McKelvey, David, Shenfield, & Jauniaux, 2009). These 
consequences may include low birth weight, neonatal death, premature delivery, pre-
eclampsia, and postpartum hemorrhaging. The consequences of multiple pregnancies also 
negatively impact the health care system (McKelvey et al., 2009), as the costs of serial 
ultrasound examinations, maternal hospitalizations resulting from complications, and 
neonatal care in the case of preterm birth are covered by public health insurance in 
Canada. These costs are often substantial. Cochrane reviews show there is low quality 
evidence to assess the incidence of multiple pregnancies resulting from IUI compared to 
other treatments (Veltman-Verhulst et al., 2016).  
                                                
1 See glossary 
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IVF is a “procedure that involves extracorporeal fertilization” (Zegers-Hochschild 
et al., 2009, p. 1522), as the eggs and sperm are combined in a laboratory dish, and the 
embryo is then transferred to the uterus. Intracytoplasmic sperm injection is a version of 
IVF in which “a single spermatozoon is injected into the oocyte cytoplasm” (Zegers-
Hochschild et al., 2009, p. 1523); this is most often used if there is a problem with sperm 
motility. 
In 2014, IVF success rates were around 40% (of procedures done) in Canada 
based on self-reported success rates by Canadian fertility clinics (BORN Ontario, 2015). 
The rate varies depending on a woman’s age, whether the embryo transferred was fresh 
or frozen, how many embryos were transferred, and other factors that influence fertility 
(BORN Ontario, 2015). However, a Cochrane review cites a slightly lower success rate 
(35.5%) for clinical pregnancy2 resulting from embryo transfer (Kroon, Hart, Wong, 
Ford, & Yazdani, 2012). Clinical pregnancies do not necessarily mean live births; 
therefore, the actual percentage of take-home babies may be considerably smaller. 
Cryopreservation is the freezing of gametes3, zygotes4, embryos, or gonadal tissue 
for later use (Zegers-Hochschild et al., 2009). Patients will use this service if they are 
storing embryos for future transfers (frozen embryo transfers) or looking to preserve their 
fertility. They may preserve their fertility for a variety of reasons including postponing 
parenthood to focus on a career, receiving a cancer diagnosis that requires treatment that 
                                                
2 See glossary 
3 See glossary 
4 See glossary 
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will render them infertile (Jeruss & Woodruff, 2009), or undertaking hormone therapy 
and/or sex reassignment surgery if they are transgender (Coleman et al., 2012).  
2.2.2 Assisted reproduction regulation in Canada.  
Certain aspects of assisted reproduction and fertility services are tightly regulated 
in Canada in order to correspond with social and ethical standards, however, the 
regulation process occurred over a number of years. 
In Canada, the federal government set up the Royal Commission on New 
Reproductive Technologies in 1989 with the purpose of creating policy recommendations 
for the management of ARTs (Royal Commission on New Reproductive Technologies, 
1993). According to Montpetit et al. (2004), the Royal Commission was expected to 
examine 
the medical and legal issues involving these technologies; their implications for 
women’s reproductive health and well-being; their social and legal arrangements, 
such as surrogacy; and ‘ownership’ rights and economic and commercial 
considerations, such as research funding and marketing regulations. (p. 145)  
 
The Commission released their final report, Proceed with Care, in 1993. The 
report recommended a ban on human cloning, surrogacy, the creation of human/animal 
hybrids, and the sale of gametes (Miller Chenier, 1994). It also recommended the 
regulation of  
sperm collection, storage, and distribution, and the provision of assisted 
insemination services; assisted conception services, including egg retrieval and 
use; prenatal diagnosis; research involving human zygotes (embryo research); and 
the provision of human fetal tissue for research or other specified purposes. 
(Royal Commission on New Reproductive Technologies, 1993, p. xxxiii) 
 
The Commission was criticized for their poor consultation process, including “an 
intimidating and dismissive hearing atmosphere” (Jones & Salter, 2010, p. 424), lack of 
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assistance with costs associated with travel and child-care, and socio-cultural insensitivity 
(Jones & Salter, 2010). After the Commission received negative feedback, the 
government held consultations with the public through Health Canada (Montpetit et al., 
2004). The Human Reproductive and Genetic Technologies Act (Bill C-47) was then 
introduced in 1996, but died on the order paper, when an election was called (Montpetit 
et al., 2004). 
Following the failure of Bill C-47, the government transferred the responsibility 
of preparing a bill to a Special Project Division within Health Canada and commenced 
new consultations with a diverse group of interested parties, including allied health 
workers, bio-ethicists, women’s organizations, infertility counselors, and family planning 
counselors (Montpetit et al., 2004; Scala et al., 2005). In 2004, An Act Respecting 
Human Reproduction and Related Research (Bill C-6), which prohibited payment for 
reproductive tissues and services among other technologies, was finally adopted (Jones & 
Salter, 2010). This Act led to the recommendation that the Assisted Human Reproduction 
Agency of Canada be created in 2006 (Jones & Salter, 2010), which was “mandated to 
protect the health of Canadians in relation to ARTs and apply ethical principles in 
embryo research” (Montpetit et al., 2004, p. 153). The agency was never formally 
established, and disbanded in 2012 because it failed to implement regulatory regimes for 
ARTs due to bickering amongst different factions asking for strict regulation of fertility 
clinics and those that wanted self-regulation by the clinics (Mulay & Boscoe, 2014). 
In Canada, many ARTs are legal, and in a few cases, publicly funded. The process 
of regulating ART access began in the 1980s and became necessary in order to ensure 
 14 
that social and ethical aspects were fully considered (Montpetit et al., 2004). During the 
process of implementing federal legislation related to ARTs, Québec was particularly 
vocal about the inappropriateness of federal policies on reproductive health issues, as 
health is a provincial responsibility (Mulay & Boscoe, 2014). Provincial governments 
have since implemented their own policies on reproductive service coverage (Health 
Canada, 2014). 
2.3 Health Care Management and Funding in Canada 
 Although the federal government has implemented regulations that criminalize 
certain reproductive technologies in Canada, they have little power when it comes to the 
management and coverage of these services. Fertility services are considered a health 
service and as a result provincial governments get to decide whether or not these services 
are “medically necessary” and the extent to which they are covered. 
2.3.1 Federal government responsibilities.  
The federal government is responsible for developing national baseline standards 
for health care services under the Canada Health Act (Deber, 2014). As health care is 
under provincial jurisdiction, provinces and territories are provided with financial support 
from the federal government for these baseline services if they meet the national 
standards outlined in the Canada Health Act (Deber, 2014; Health Canada, 2011). This 
federal financial contribution, under what is now called the Canada Health Transfer, is 
based on various factors, including population size and fiscal capacity (Deber, 2014; 
Health Canada, 2011). The federal government is also responsible for funding and 
delivering health care for specific populations including “First Nations people living on 
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reserves, Inuit, serving members of the Canadian Forces, eligible veterans, inmates in 
federal penitentiaries, and some groups of refugee claimants” (Health Canada, 2011, 
para. 18). 
The Canada Health Act has five governing principles: public administration, 
comprehensiveness, universality, accessibility, and portability (Health Canada, 2011). 
Public administration means that a public authority managed by the provincial or 
territorial government must administer health services (Deber, 2014; Health Canada, 
2011; Madore, 2005). Comprehensiveness implies that provincial and territorial health 
plans must insure all medically necessary services provided within a hospital or by 
physicians. Universality means that everyone who is eligible is insured and that everyone 
who is insured is entitled to equal service coverage. Accessibility is that governments 
must provide all who are insured reasonable access to the insured baseline health 
services, without cost-associated barriers. Portability means that health coverage applies 
between provinces and usually for emergency and other necessary treatment received 
abroad (Deber, 2014; Health Canada, 2011). 
Outside of health insurance, the federal government is responsible for health 
protection and regulation (e.g., regulation of pharmaceuticals), consumer safety, disease 
surveillance and prevention (Health Canada, 2011). Additionally, it provides support for 
health promotion and research and health-related tax credits or deductions for particular 
groups of people, for example deductions on health insurance premiums for those who 
are self-employed (Health Canada, 2011).  
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2.3.2 Provincial and territorial government responsibilities.  
The provincial and territorial governments are responsible for administering and 
delivering the majority of health care services, held to the national standards of the 
Canada Health Act (Health Canada, 2011). The provincial/territorial health plans cover 
all medically necessary hospital and physician services without requiring payment for the 
service by the insured patient (Health Canada, 2011). Medically necessary services are 
not defined by the federal government in the Canada Health Act, but rather by provincial 
and territorial governments in consultation with physician groups (Health Canada, 2011). 
Many governments will also cover additional benefits for certain groups (i.e., seniors and 
low-income residents), including the cost of ambulance services and medications 
prescribed outside of hospitals, as well as audiology, optometry, and dental services 
(Health Canada, 2011). These services are normally not covered by public health 
insurance, but by private or employment-based insurance or they may be paid out-of-
pocket by patients. Fertility services are also not universally covered by Medicare, which 
means that they may be less accessible depending on the province in which one lives.  
2.3.2.1 Provincial reproductive service coverage and access.  
As each province and territory individually manages and delivers their own health 
plans, there are usually many differences between them (Health Canada, 2014). Even 
though infertility treatments are not considered medically necessary by most provincial 
governments, Québec and Ontario publicly fund some treatments (Morin, 2015; Motluk, 
2015). Manitoba provides a tax credit for up to 40% for fertility treatment costs with a 
maximum tax credit of $8,000 each year (Boyajian et al., 2014; Motluk, 2015). Ontario 
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used to cover only the cost of IUI, but in late 2015, it started covering the cost of one 
round of IVF (Motluk, 2015). In contrast, due to unsustainability and strain on the health 
care system, the Québec health plan, which used to cover three rounds of IVF treatment, 
now only covers one round (Morin, 2015). However, it continues to cover the cost of IUI 
for women aged 18-42 (Morin, 2015).  
In NL, the provincial health plan (MCP) covers infertility diagnosis, including 
blood tests, sperm counts, laparoscopy, and ultrasounds, as well as doctor appointments, 
but not fertility drugs, sperm washing for IUI, or IVF (T. O’Grady & H. Rees, personal 
communication, September 15, 2015). NLFS offers services such as prescription and 
administration of fertility drugs to stimulate increased egg production, cryopreservation 
of male gametes for medical reasons, and IUI (T. O’Grady & H. Rees, personal 
communication, May 25, 2015). However, there are no IVF (or intracytoplasmic sperm 
injection) services available in the province and the procedure is not covered under the 
provincial health plan, which means that patients pay not only for the procedures, but also 
for the costs associated with travelling out-of-province to access the services. Patients 
who want to access IVF (or intracytoplasmic sperm injection) have to travel to Halifax, 
Ottawa, or Calgary. An estimated 80 to 100 couples travel outside the province to access 
IVF each year (T. O’Grady & H. Rees, personal communication, May 25, 2015). NL is 
one of two provinces (the other is Prince Edward Island [PEI]) that does not offer IVF 
services in the province (Canadian Broadcasting Corporation [CBC], 2014). According to 
O’Grady and Rees (personal communication, September 15, 2015), this is due to a lack 
of funding from the provincial government. Moreover, given the province’s small 
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population, the demand for service is expected to be low and, therefore, the quality of 
service would likely also suffer. Even though both NL and PEI do not offer IVF services, 
the challenges that NL residents experience are likely greater due to the isolation of the 
province, but this has not been explored in the literature. Therefore, the purpose of this 
study is to examine challenges faced by NL fertility patients.  
2.4 Access Issues 
Cost is often a factor for those accessing fertility services. It may affect the type 
of service they choose, where they go to access services, or both. Out-of-pocket costs and 
socio-economic status create inequity in service access: people who are more financially 
secure can access fertility services more easily. 
2.4.1 Out-of-pocket costs and socio-economic status.  
Collins et al. (1997) examined the prevalence of infertility, infertility service 
distribution, and the costs associated with certain reproductive treatments in Canada in 
1995. They used survey results from the Royal Commission for New Reproductive 
Technologies and from the Canadian Infertility Treatment Evaluation Study, as well as 
cost-related information from Chedoke-McMaster Hospital in Hamilton, Ontario in order 
to determine the cost of infertility treatments (Collins et al., 1997). They found that of the 
330,000 Canadian couples experiencing infertility in 1995, less than half accessed 
fertility treatment, and 13 diagnostic and treatment categories covered the majority of the 
services utilized (Collins et al., 1997). Costs associated with infertility treatment ranged 
from $229 per clomiphene5 administration to $41,000 for IVF per live birth (Collins et 
                                                
5 Clomiphene is a drug used to stimulate ovulation 
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al., 1997). They concluded that the annual cost of infertility care in Canada was $415 
million, which was 0.6% of the annual cost of health care at the time (Collins et al., 
1997). In 1995, one cycle of IVF (including clinic visits, injections, medications, 
monitoring, and physician, hospital, and lab fees) cost $5,700 (Collins et al., 1997). In 
Canada today, one IVF cycle may range between $7,000 and $15,000 (Picard, 2011). 
Clinics in Halifax, Ottawa, and Calgary all quote a basic IVF fee over $6,200, which 
includes pretreatment evaluation, consultation, monitoring, as well as surgical, 
anaesthetic, and laboratory fees. It does not include drug costs.  
Patients often have to rely on personal finances to cover the costs of fertility 
services, but some private health insurance plans have limited coverage for infertility 
drugs, which can help lower out-of-pocket expenses. In 2015, 24 million Canadians had 
some level of supplementary health insurance (Canadian Life and Health Insurance 
Association [CLHIA], 2016). Most private health insurance comes from employers, 
which means that private coverage is less available to those who are unemployed (Hurley 
& Guindon, 2008). Those who are underemployed, seasonally employed, or working 
certain types of jobs, such as some retail positions, may also be lacking private health 
insurance. Both Smythe (2001) and Bhatti, Rana, and Grootendorst (2007) found that 
those with higher incomes were more likely to have private health and dental insurance. 
With the high cost associated with infertility treatments, patients accessing fertility 
services are more likely to be in middle or upper income brackets, and have some level of 
private health insurance coverage. 
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Many global studies demonstrate the inaccessibility of infertility care for low-
income individuals (Inhorn & Fakih, 2006; Makuch, de Padua, Petta, Osis, & 
Bahamondes, 2011). Jain and Hornstein (2005) examined the demographic and 
socioeconomic characteristics of patients accessing fertility services in Massachusetts. 
The Center for Reproductive Medicine Clinic at Brigham and Women’s Hospital mailed 
questionnaires to collect demographic information. They found that the majority of 
people accessing these services were Caucasian, educated, and financially well off (Jain 
& Hornstein, 2005), which suggests that socio-economic conditions, especially income 
level, affect a patient’s ability to access fertility services. Even though the Canadian and 
American health care systems differ greatly, neither has universal coverage for fertility 
services. Therefore, Canadians may also be less likely to access fertility services if they 
have a lower income, as seen in the American study by Jain and Hornstein. 
The literature seems to be lacking up-to-date information about the cost of fertility 
services in Canada and how cost impacts service access. This study examines the costs 
patients are faced with when accessing fertility services, considering factors such as 
socioeconomic status, insurance coverage, and location of residence to contextualize the 
data. 
2.4.1.1 Effect of costs on treatment decisions.  
The cost of health care services and medications often impacts treatment 
decisions made by patients. Bayliss, Steiner, Fernald, Crane, and Main (2003) 
interviewed 16 adults from Denver, Colorado with comorbid chronic diseases about the 
barriers they face when practicing self-care. Financial problems were cited among half of 
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the participants, specifically that paying for medications made adhering to self-care 
difficult. Cotton, Aspy, Mold, and Stein (2006) interviewed nine family physicians in 
Oklahoma about clinical decision-making in blood pressure management of patients with 
diabetes. They found that treatment options were limited for these patients most 
frequently by high cost of medications and inadequate insurance. Patients were being 
treated differently based on financial situations. Bernheim, Ross, Krumholz, and Bradley 
(2008) interviewed 18 physicians in Connecticut about how patient socio-economic status 
influenced clinical management decisions and found that physicians would change their 
treatment plan to improve patient outcomes, but struggled to balance treatments that were 
financially feasible for the patient with established standards of care. These studies are all 
American and unrelated to fertility care, however they highlight how treatment decisions 
may be affected by the cost of fertility services, a publicly uninsured service.  
When considering infertility care specifically, it is clear that high financial costs 
prevent patients from accessing services and impact treatment decisions (McDowell & 
Murray, 2011; Redshaw, Hockley, & Davidson, 2007). Makuch et al. (2011) interviewed 
Brazilian infertility health professionals and patients and found that patients oftentimes 
could not afford their treatment medications. Therefore, these patients rarely received 
treatment. In a study by McDowell and Murray (2011), IVF patients at a centre in New 
Zealand were surveyed over a 3-year time period. The survey collected demographic 
information, treatment outcomes, and reasons for discontinuing treatment, if applicable. 
Patients reported discontinuing treatment due to failure to achieve pregnancy, cost (e.g., 
exhaustion of available public funding and high cost of private treatment), and stress. The 
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discontinuation of IVF treatment as a result of exhausted financial resources was also 
reported by Turkish patients in a study by Akyuz and Sever (2009). These studies 
demonstrate the financial barriers associated with accessing infertility care worldwide. 
We were unable to find Canada-centric data related to these challenges and how 
treatment is impacted. Unlike the United States and most other countries, some fertility 
treatments are covered in Canada by public health insurance; this varies from province to 
province and as a result, financial burden also varies depending on geographic location. 
This study addresses the gap in the literature on how infertility treatment decisions are 
affected by cost in Canada. 
2.4.2 Rural residents.  
Access to health services is especially challenging for rural residents who often 
travel great distances for routine appointments and treatments (Fuchsia Howard et al., 
2014; Kornelsen & Grzybowski, 2006; Mathews, West, & Buehler, 2009). In terms of 
fertility services in NL, rural residents must not only travel to access IVF out-of-province 
if they so choose, but must also travel to St. John’s for diagnostic services and 
preliminary treatment. 
Furthermore, rural residents are less likely to have private health insurance and 
are more likely to be underinsured than urban residents (Bennett & Dismuke, 2010; 
Ziller, Coburn, & Yousefian, 2006). This is due to the types of employment that are more 
common in rural areas (e.g., working for small businesses and self employment), lack of 
unionization, and limited availability of group coverage (Bennett & Dismuke, 2010; 
Probst, Moore, Glover, & Samuels, 2004; Ziller et al., 2006). 
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Redshaw et al. (2007) surveyed women in the United Kingdom (UK) who had 
been treated for infertility about the nature of their treatment and associated financial 
costs. Some of the women reported financial and emotional costs resulting from the lack 
of locally available infertility care. They experienced difficulties associated with 
travelling for treatment, time lost from work, and scheduling childcare (Redshaw et al., 
2007). Although we were unable to find Canadian studies related to geography and 
fertility service access, this study highlights some of the challenges that might be 
experienced by rural fertility patients in Canada. 
A local example of the impact of geography on treatment decisions is provided by 
an NL cancer study. Mathews, West, and Buehler (2009) surveyed NL cancer patients 
between September 2002 and June 2003 and found that rural residents were more likely 
to report that costs resulting from travel, drugs, and childcare were important to their 
treatment decisions. Those without private insurance and those with low income also 
reported the same concerns. The study demonstrates the inequity in the health care 
system, as rural residents, those without private insurance, and those with low incomes 
are more affected by financial barriers related to accessing care. Although this study 
examines the experiences of cancer patients, all patients who are isolated from the service 
they wish to access, as well as those without private insurance and/or those with low 
income, may encounter similar challenges. If cost affects the treatment decisions made by 
cancer patients, whose care is often considered necessary, then it will certainly impact the 
treatment decisions made by fertility patients. The impact of cost on fertility treatment 
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decisions, specifically for rural Canadian patients, has not been examined in the 
literature; this research attempts to fill that gap. 
2.4.3 Service provider perceptions.  
When examining the challenges patients face while accessing fertility services, it 
is important to consult service providers to obtain a holistic picture of these challenges 
and how treatment is impacted. Mathews, Buehler, and West (2009) interviewed NL 
cancer care providers about their perceptions of how patients and providers try to limit 
out-of-pocket costs resulting from cancer care. These out-of-pocket costs were separated 
into three categories: (1) drugs, medical supplies, and equipment; (2) travel and lodging; 
and, (3) loss of income. Service providers reported patients trying to curtail costs by 
substituting or rationing medications, choosing radical treatments, lengthening the time 
between follow-up appointments, choosing inpatient care, and working during treatment 
to minimize loss of income. Service providers would try to minimize costs for patients by 
changing chemotherapy and supportive drug prescriptions, shortening radiation treatment 
protocols, admitting patients to hospital, and arranging follow-up with physicians closer 
to a patient’s home. Some of these methods of minimizing cost obviously affect patient 
treatment and care, such as changing or rationing medications, shortening treatment 
protocols, and spacing follow-up appointments farther apart.  
Although this study is about cancer care, it offers insight into service providers’ 
perspectives on the ways that patients and providers alter treatment plans based on out-
of-pocket costs. We could not find anything in the literature specifically about how the 
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challenges associated with fertility care affect treatment decisions of patients and 
providers from the perspective of service providers, so this research aims to fill this gap.  
2.5 Summary 
 This chapter presents a case for research related to the challenges patients face 
when accessing fertility services in NL. By describing the variation in infertility 
definitions in the literature and highlighting the rising prevalence of infertility, it 
demonstrated the demand for fertility services. It also placed fertility services in the 
context of the Canadian health care system and NL’s provincial health plan, and 
borrowed from literature on other health conditions and service access issues. Finally, it 
summarized findings from studies on cost impact on uninsured care in general and on 
health services in Canada, which highlighted the need for evidence that reflects the local 
circumstances.   
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3.0 Methods 
This project used in-depth qualitative interviews and consisted of a patient study 
and a service provider study. We adopted a pragmatic epistemology, which incorporates 
both realist and idealist ontologies, and approaches research practically, suggesting that 
real-world problems guide the interests of researchers (Giacomini, 2010). It asserts that 
“phenomena operate independently of our ideas, but also grants that we must apprehend 
these phenomena through our ideas” (Giacomini, 2010, p. 132). 
In-depth qualitative interviews are helpful for understanding and documenting the 
experiences of study participants (Miller & Glassner, 2011). They allow for the 
interviewer to explore the participant’s point of view and to represent it as truthfully as 
possible. This method can be used “for examining the social world from the points of 
view of research participants” (Miller & Glassner, 2011, p. 137). Green and Thorogood 
(2009) describe an interpretative approach to research in which the researcher seeks to 
understand people’s interpretations of ‘reality’; the in-depth interviews are useful for this 
approach as they target participant “accounts of the world, not direct representations of 
that world” (p. 102). In-depth interviews offer data that represent the interaction of the 
researcher and the participant to reveal information about what participants believe and 
how they behave, classify the world, and categorize knowledge; interview data are valid 
as long as they are not taken out of context and used as a representation of another reality 
(Green & Thorogood, 2009).  
3.1 Patient Study 
For the patient study, we used semi-structured, in-depth interviews with patients 
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from NLFS to realize the first three research objectives. These were (1) to describe the 
challenges experienced by patients seeking infertility treatment in NL, (2) to explore 
whether or not there is a difference in the challenges experienced by patients seeking 
infertility treatment who are from St. John’s and surrounding areas (within 50 km of 
NLFS) compared to those who are from other areas of the province (farther than 50 km 
away), and (3) to understand how these challenges impact patient treatment and travel 
decisions. 
3.1.1 Participant recruitment.  
Participant recruitment began in March 2016 and ended in June 2016. Three 
approaches were used to recruit participants. First, we messaged the administrators of the 
Facebook groups, “Infertility Support – Newfoundland and Labrador” and “Parents 
helping parents with everyday questions about parenting – NL”, explained the study, and 
requested that they share information about the study as well as the research team’s 
contact information on their page. We also placed recruitment posters in the NLFS clinic. 
Finally, we asked participants to pass along the research team’s contact information to 
anyone they knew who might be interested in participating. Potential participants 
contacted the research team in order to participate or to ask for more information about 
the study.  
3.1.2 Inclusion and exclusion criteria.  
To be included in this study, the participants must have been referred to NLFS 
between December 2010 and December 2014, to ensure that they had been treated 
relatively recently, thereby improving their ability to recall experiences. Only women 
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were included in the study because the fertility drug treatments, IUI procedures, and IVF 
procedures involve women. Moreover, men and women likely experience infertility 
differently (Newton et al., 1999). Examining the difference between how men and 
women experience infertility was beyond the scope of this study. Participants had to be 
between the ages of 25 and 50 at the time of recruitment, which was defined as the 
appropriate age range for reproduction in this study, as patients in this age group were 
more likely to be accessing or to have recently accessed fertility services. Patients who 
did not intend to personally become pregnant as soon as possible were excluded from this 
study (e.g., those who used surrogacy or cryopreservation). We confirmed participant 
eligibility over email and during the interview by asking about time of referral, sex, birth 
year, and what services were accessed. 
Participants were purposefully sampled based on location of residence. An 
attempt was made to interview patients who traveled to the clinic from farther than 50 km 
away and patients living within 50 km of NLFS.   
3.1.3 Data collection.  
Participants were offered the option of an in-person or telephone interview. All 
interviews were held over the phone and conducted in a private room. Participants were 
required to sign and return a consent form before participating in the study. In addition, 
consent was reconfirmed verbally at the beginning of the interview. The patient 
participants completed a brief questionnaire at the beginning of their interviews to collect 
demographic information, including age, location of residence, whether or not they have 
private health insurance, marital status, and household income. The questionnaire is 
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presented in Appendix I.  
The interviews consisted of semi-structured questions related to the patient’s 
journey to accessing fertility care, the types of services accessed and considered, the 
factors that influenced the services accessed and considered, the types of costs that they 
incurred throughout the treatment process, how the cost of treatment and travel 
influenced treatment decisions, and whether the patient would consider accessing 
services in the future. The interview guide is presented in Appendix II.  
The interviews were recorded digitally and transcribed verbatim. Recruitment and 
interviews continued until saturation of themes and concepts occurred, which means that 
no new ideas were raised in the interviews (Mathews, Beuhler, & West, 2009). In order 
to maximize the credibility of the data and ensure that participant responses were 
properly interpreted, we used respondent validation or member-checking, which entails 
summarizing the responses and repeating them back to the participant for verification 
(Flick, 2014; Mathews, Buehler, & West, 2009). Participants had the opportunity to leave 
their contact information with the research team in order to receive the study results.  
3.1.4 Data analysis.  
The qualitative interviews were analyzed using thematic analysis, concurrent to 
data collection (Green & Thorogood, 2009). Two members of the research team (Dr. 
Maria Mathews and I) began by individually reading through three of the interview 
transcripts looking for and marking common ideas (Huston & Rowan, 1998; Mathews, 
Beuhler, & West, 2009). Based on this initial reading, we assigned names and colours to 
these common ideas, while being careful to keep the preliminary codes as distinct as 
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possible. We then compared and consolidated our coding template and coded transcripts 
that were developed from these first three interviews in order to describe codes, clarify 
misunderstandings, and develop consistency among the codes (Mathews, Beuhler, & 
West, 2009; Rowan & Huston, 1997). During this meeting we also began to define and 
describe the codes. We finalized the code descriptions and then used the coding template 
to re-code the first three interviews. We coded by going back through the transcripts and 
highlighting ideas related to the codes in the same colour as the code. The remaining 
interviews were coded with this final coding template and then coded quotations were 
grouped using NVivo 11 software (QSR International [Americas], Cambridge, MA, 
U.S.A.). NVivo is used to group coded interview or focus group data in order to organize 
quotations under a specific theme. 
3.2 Service Provider Study 
For the service provider study, we used semi-structured, in-depth interviews with 
service providers at NLFS to realize the fourth research objective, which is to determine 
how the challenges that patients face affect the provision of care from the perspective of 
service providers. 
3.2.1 Participant recruitment.  
Participant recruitment began in May 2016 and ended in June 2016. To recruit 
nurse participants, we presented at a nurse staff meeting. We briefly explained that the 
study intended to determine the barriers to accessing fertility services in NL and that they 
would be asked to participate in a recorded interview. During this meeting, the nurses 
decided on times that we should come to the clinic for interviews and coordinated 
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amongst themselves who would be interviewed based on their interest and who was 
answering patient phone calls and not working directly with patients in the clinic. We 
emailed out consent forms following this meeting so that they could read and sign the 
form prior to the interview.  
We also sent an email to physicians employed at NLFS. The email contained 
information about the study and those interested in participating were able to contact the 
research team to schedule an interview. Administrative staff identified times when 
interested physicians were available. To ensure that participation was voluntary, consent 
was confirmed verbally in a private room before the interview began.  
3.2.2 Inclusion and exclusion criteria.  
To be included in this study, the service providers were physicians or nurses 
employed at NLFS. There were no other healthcare professionals that worked at the 
clinic. They also had to be employed at the clinic for at least 2 years to ensure that they 
had experience dealing with a variety of patients. 
3.2.3 Data collection.  
The service provider interviews were held in-person in various offices at NLFS. 
The interview guide is presented in Appendix III. Participants were required to sign a 
consent form before participating in the study and consent was re-confirmed verbally at 
the beginning of the interview. The interviews consisted of semi-structured questions 
related to the common barriers patients face when accessing fertility services, how 
geography and service availability impact cost and how patients finance their treatments, 
how these barriers affect the delivery of fertility services, and the assistance available to 
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patients struggling to access fertility care. The interviews were recorded digitally and 
transcribed verbatim. Interviews were done until saturation of themes and concepts was 
achieved. In order to ensure that participant responses were properly interpreted, we used 
respondent validation or member-checking (Flick, 2014; Mathews, Buehler, & West, 
2009), as described in Section 3.1.3. All participants had the chance to give their contact 
information in order to receive the study results.  
3.2.4 Data analysis.  
We analyzed the transcripts from this study using thematic analysis, as described 
in the patient study. However, instead of highlighting text in the same colour as the 
corresponding code, lettering and numbering schemes were assigned to each code and 
then used to mark sections of text that contained the same idea. The interview transcripts 
were coded and coded quotations were grouped using NVivo 11 software (QSR 
International [Americas], Cambridge, MA, U.S.A.). 
3.3 Quality Management 
 Various steps were taken throughout the research process to ensure the quality of 
the methods, data collection, and analysis. 
3.3.1 Pre data collection.  
Before beginning data collection, we pretested the interview questions by posing 
them to colleagues to assess responses, improve ways of posing the questions, and 
improve probes. We then conducted a pilot interview with someone that had previously 
used fertility services. The pilot interview was recorded, played back, and critiqued by 
Dr. Maria Mathews. The purpose of this was to listen for appropriate and inappropriate 
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responses to sensitive information, question phrasing, probe use, and participant 
responses. This interview was not used in the study. 
3.3.2 During data collection.  
Once data collection began, we recorded interviews to improve dependability and 
confirmabilty of the data (Green & Thorogood, 2009). We also reviewed completed 
interviews to improve how questions were being asked, to identify new probes for 
subsequent interviews, and to assess saturation of themes and concepts. In order to 
maximize the credibility of the data, we used respondent validation or member-checking, 
(Flick, 2014; Mathews, Buehler, & West, 2009), as described in Section 3.1.3. 
3.3.3 Post data collection.  
To maximize dependability and confirmability, we kept records of the interviews, 
including transcripts and audiotapes, as well as coding template drafts (Green & 
Thorogood, 2009; Mathews, Buehler, & West, 2009; Mays & Pope, 1995). We also used 
two members of the research team to create a coding template and code three interviews 
from each study to improve confirmability (Cope, 2014; Green & Thorogood, 2009). To 
improve credibility and dependability, we used thick description, which thoroughly 
describes the context of quotations and research (Green & Thorogood, 2009; Huston & 
Rowan, 1998; Mathews, Buehler, & West, 2009). We also described the methods and 
inclusion/exclusion criteria in detail to improve transferability and allow readers to 
compare the findings to similar situations or projects (Cope, 2014; Green & Thorogood, 
2009). Finally, we reported disconfirming evidence in our results in order to maximize 
credibility (Cope, 2014). 
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3.4 Ethical Considerations 
This research was approved by the Newfoundland and Labrador Health Research 
Ethics Board (HREB Reference #2016.028) and the Research Proposals Approval 
Committee (RPAC), which is responsible for the approval of research taking place in 
Eastern Health. 
For patient recruitment (section 3.1.1) the research team contacted administrators 
for parenting and infertility Facebook groups asking them to post a participant 
recruitment message in the group. We also had posters put up in NLFS. In both of these 
cases, we had no contact with patients unless they contacted us themselves to participate 
in the study. For the service provider study, administrative staff helped the research team 
recruit participants at NLFS, as described in section 3.2.1. However, the research team 
was careful to ensure that all service providers were participating voluntarily. The 
interviews were conducted in a private room, away from coworkers and administrative 
staff. All participants in both studies were informed of their right to withdraw from the 
study at any time and were required to read and sign a consent form before interviews 
began. 
The risks of this study were low because the questions were limited to the direct 
experience of patients seeking and obtaining fertility services in relation to distance and 
cost. However, it was possible that patient participants may have felt stressed or 
emotional when discussing their experience with infertility and accessing fertility 
services; therefore, we were prepared to recommend support services through NLFS if 
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necessary. Dana Ryan, Dr. Mathews’ research assistant who has a Master’s degree in 
counseling, was also present to provide emotional support in case it was needed. 
Confidentiality of all participants was maintained by using numbers to identify 
participants in transcription and analysis. Additionally, letters were used instead of names 
for physicians that were identified in patient interviews (e.g. Dr. X). Participants were not 
and will not be identified in publications or presentations; this means that any specific 
information that could identify participants was and will be edited in publications and 
presentations, such as age or gender of NLFS staff.  
In order to keep all data secure, they were stored in locked rooms, out of sight. 
Electronic files were password protected with only Dr. Mathews, Dr. Mulay, and myself 
able to access the data. After the 5 year time period outlined in the university research 
guidelines has passed, the interview data will be destroyed.  
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4.0 Patient Study Results 
4.1 Description of Sample Population  
There were 14 women who expressed interest in this study and 11 (78.6%) of the 
14 completed interviews. The remaining three women did not respond to follow-up 
emails. The interviews lasted between 20 and 45 minutes. Participants were from across 
the island of Newfoundland, but none were from Labrador. They were between 30 and 45 
years of age at the time of interview. Three participants (27.3%) lived more than 50 km 
away from St. John’s. All but one participant were married or in common law 
relationships. One (9.1%) was single.  Participant household incomes ranged from less 
than $20,000 to over $100,000, however the majority of participants (63.6%) fell in the 
$100,000 and above income bracket. Four of the 11 participants (36.4%) had already had 
children through fertility services. One (9.1%) was actively seeking treatment and two 
(18.2%) were pregnant at the time of the interview, while others were taking a break or 
had stopped treatment altogether.  
In order to give context to quotations, some patient information is provided, 
including an identification number, location of residence (urban or rural), treatment 
received, and pregnancy outcomes. 
4.2 How and Why Patients Use Fertility Services 
Before using fertility services, most patients reported trying to get pregnant for at 
least a year. Patients tried ovulation kits, different fertility tracking smartphone 
applications, and tracking their body temperature in order to optimize their chances of 
becoming pregnant. The women were referred to fertility services for many reasons. 
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Some had no obvious reasons to explain why they were not getting pregnant, others 
needed sub-specialist expertise to treat co-morbid conditions to become pregnant, and 
many suffered from multiple miscarriages before finally being referred to fertility 
services. 
 One woman started trying to get pregnant in 2010 and was referred to the fertility 
clinic in 2011. She tried various methods to get pregnant before seeking specialized care. 
Her menstrual cycles were regular, so there was no obvious indication of why she could 
not become pregnant. 
Prior to fertility [services] I was tracking my cycles, tracking my temperatures, 
ovulation kits etc. just so I would know roughly when I was ovulating and all of 
that stuff. So I had lots of data when I finally went to the fertility clinic (Patient 7, 
urban, IUI and IVF, 1 child). 
 
Another woman tried for a year to get pregnant before being referred to fertility services. 
She also reported trying different methods to become pregnant before accessing fertility 
services and having regular menstrual cycles, but still could not become pregnant.  
We were doing the ovulation strips and I was tracking my basal temperature and 
all that stuff, so we felt like we knew when I was ovulating, like it was pretty 
clear from all of that, so we knew that we were getting the timing right and my 
cycle was fairly regular. So we thought that every month we basically had a good 
shot of getting pregnant, but we never did (Patient 8, urban, medicated cycles, 1 
child). 
 
Other patients with more apparent symptoms of infertility and comorbid 
conditions were treated by their family doctor or obstetrician/gynecologist (OBGYN) 
before going to fertility services. When these women did not become pregnant with this 
treatment, they chose to move on to sub-specialized fertility care to improve their 
chances. For example, one woman from a rural area was initially treated by her 
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obstetrician on the west coast of Newfoundland before being referred to fertility services. 
She found out after visiting the fertility clinic that she had blocked fallopian tubes and 
that IVF was her only option to become pregnant. 
I had been doing fertility treatment with my OBGYN for a few years…say 2008, 
2009, then I was referred to a new OBGYN once my [old OBGYN] retired. So 
same kind of thing, doing fertility drugs, Clomid and Fermara, and nothing was 
working… so I think it was probably around 2011 [that] I was referred to 
Newfoundland and Labrador Fertility Services (Patient 1, rural, IVF, 1 child). 
 
Another woman had Polycystic Ovarian Syndrome (PCOS), a condition that prevented 
her from becoming pregnant. After months of receiving treatment from her OBGYN in 
St. John’s, she was referred to fertility services. 
My family doctor sent me to an OBGYN and she did a bunch of tests and we 
eventually figured out that I have…PCOS. So I did 3 months of a drug called 
Clomid that was prescribed by the OBGYN and actually got pregnant in July of 
2014 and I miscarried at 10 weeks…[the OBGYN] had referred me to fertility 
services in January when I first saw her…because she said she could only 
prescribe 3 months of the fertility drug and after that it would have to be taken 
over by fertility [services] (Patient 6, urban, IUI, pregnant). 
 
 Many patients suffered multiple miscarriages while trying to become pregnant, 
due to comorbid conditions or for other unknown reasons, which pushed them to access 
fertility services directly. One woman had a heart condition, which made achieving and 
maintaining a pregnancy difficult. After a year of trying to get pregnant with tracking and 
ovulation kits, she was referred to the fertility clinic after a miscarriage. 
My partner and I had been trying to get pregnant for quite a while and we finally 
did, and then at about 9 weeks I started having a lot of pain, went for an 
ultrasound and found out that I miscarried. So my doctor at the time had referred 
me to [fertility services] (Patient 5, rural, diagnostic services, 1 child). 
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After two miscarriages, one patient pushed for a fertility services referral even though she 
said physicians normally withhold referrals until after three miscarriages. By the time she 
actually saw fertility services she had had four miscarriages.  
My husband and I first started trying to get pregnant and have a child in [2010]. 
So we got pregnant in 2010 and I had my first miscarriage…we got pregnant 
fairly quickly, it just took a few months of trying so no one at that point in time 
thought there would be any sort of an issue or didn’t feel there was any need to do 
any investigations. So the summer of 2011 I got pregnant and I had another 
miscarriage at about eight weeks and so at that point in time...I felt that there was 
some sort of an issue that prompted me to see my family doctor and really push to 
get a referral despite the fact that they don’t like to do that until you’ve had three 
losses. By the time I finally saw [fertility services] in 2012, I was after having 
four [miscarriages] (Patient 7, urban, IUI and IVF, 1 child). 
 
The women in this study all tried to achieve and maintain a pregnancy on their 
own before using fertility services, but could not because of unknown reasons, comorbid 
conditions, and multiple miscarriages.  
4.2.1 Services used and considered.  
Participants accessed and considered a variety of services both locally and in 
other provinces, including diagnostic services, drugs, IUI, IVF (both fresh and frozen 
transfers), ICSI, cryopreservation, male sterilization reversal procedures, gamete 
purchasing or donation, and treatment for comorbid conditions. The most common 
reasons for patients accessing services were their inability to conceive, suffering multiple 
miscarriages, and advanced age.  
Patients reported trying multiple rounds or types of services before achieving a 
pregnancy. A woman from the St. John’s area who used IUI six times and IVF three 
times began with IUIs at the local clinic. She and her husband decided to “try IUI and see 
if it works, so we did six consecutive cycles of IUI and didn’t have a single pregnancy” 
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(Patient 7, urban, IUI and IVF, 1 child), which motivated them to move on and try IVF. 
Many patients reported that they started with IUI in St. John’s and after multiple IUI 
failures they moved on to IVF.  
4.3 Barriers to Accessing Fertility Services 
Through the interviewing process, we looked to identify the largest challenges 
that patients face when accessing fertility services in NL and how these challenges 
affected decision-making. The main barriers identified by patients were cost, the nature 
of fertility services, the physical environment, lack of service availability, and geography.  
4.3.1 Costs and financial burden.  
There are both direct and indirect costs that result from using fertility services. 
Direct costs are any costs specifically related to fertility treatment, including procedures, 
cryopreservation, and drugs. Indirect costs contribute to the overall cost of using fertility 
services, but are not part of treatment itself, such as travel-related expenses and time 
taken off work.  
Direct costs of fertility treatment result mainly from IVF related costs and drug 
costs for all treatments, as IUI is largely covered by NL’s provincial health plan. Without 
private insurance coverage patients may pay thousands of dollars for fertility drugs. For 
example, one patient who had used all of her insurance coverage after her first IVF cycle 
paid for her second fresh IVF cycle out-of-pocket, noting that the drug costs were 
probably around six or seven thousand dollars. She also described the additional costs 
associated with her second IVF cycle, saying “we paid the standard IVF cost, plus we had 
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to pay for ICSI for fertilization for that cycle so that’s an extra cost, plus they did assisted 
hatching so that’s an extra cost” (Patient 7, urban, IUI and IVF, 1 child). 
Although direct costs can be substantial, especially for patients availing of IVF, 
indirect costs can be as equally burdensome. Some patients reported losing money from 
the time they take off work for their appointments and treatment-related travel. They 
described situations of having exhausted their sick leave and vacation time forcing them 
to take days off without pay. For example, a woman who travelled to Calgary for IVF 
said, “I actually exhausted all my sick leave….I have zero sick days right now…I just got 
back from Calgary in September with failed cycles…so I take days without pay. That’s 
the only way that I can go to my appointments” (Patient 1, rural, IVF, 1 child). Another 
patient who had five IUIs in St. John’s also reported using all of her sick leave. She 
intends to leave the province to access IVF by the end of 2016: 
A lot of my [sick leave] time went towards [fertility] appointments and if I didn’t 
have any sick leave left I was taking my vacation leave… and now when I go 
away for IVF I have to take that all unpaid sick leave because I have no time left 
vacation or sick leave… and that would be for myself and my husband…even if 
we do have a higher income you still don’t save for that kind of expense (Patient 
11, urban, IUI, no children). 
 
A woman who had eight IUIs in St. John’s reported losing as much as a full day of work 
during each month of treatment. 
There’s the not so upfront cost of having to take time off work for all of the 
appointments that you go to. I mean six/seven appointments per cycle. That’s a 
pretty substantial amount of time off work to go to those appointments, especially 
because there are times when you have an appointment at 9 o’clock in the 
morning and you don’t get seen until 11. By the time I leave work, drive there, 
have the appointment, come back…[it could be] 7/8 hours per month, so a full 
day’s work really that I would lose per month (Patient 3, urban, IUI, pregnant). 
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Patients reported travelling both within the province and between provinces to 
access services, which increased the costs they incurred throughout the treatment process. 
Travelling within the province contributed to the cost of fertility treatments, as 
accommodations, food, and gas increased costs. For example, a woman who was being 
treated in St. John’s had to drive roughly two hours to get to her appointments. She noted 
that hotels were necessary at times due to poor weather conditions. 
There’s the travel expenses. So I mean you’re driving in, so first of all you’re 
losing a day at work, and then gas and accommodations and meals because you’re 
in there a for full day and sometimes a day and a half…you’re probably spending 
60 or $80 on gas and then a hotel and everything else if need be (Patient 5, rural, 
diagnostic services, 1 child). 
 
Women who had to travel to other provinces in order to access IVF services 
reported even more substantial costs. Normally, their flights were expensive and their 
stays were long, which all contributed to cost. For one woman, travelling to Calgary to 
receive IVF treatment impacted her overall treatment cost: 
Our [IVF] procedure was just shy of $8,000. Then you have the drugs. Luckily 
my insurance…covered a lot. So I probably had to spend around $1,500 in drugs. 
Then of course our airfare which was around $2,000 and…we didn’t have to pay 
for a hotel, so you know we did it I guess as cheaply as possible…I would say we 
probably spent in total our first time…around $12,000 (Patient 1, rural, IVF, 1 
child). 
 
Similarly, another woman who also travelled to Calgary for IVF noted the costs 
associated with travel. 
If I think about my first [IVF] cycle, the cycle itself was probably 10 or 12 
thousand, the drug cost I would say that was probably six or seven thousand, 
flights you’re looking at $1,200 a person. I mean we were lucky we didn’t have to 
pay for accommodations but most people would and you’re lucky if you can get 
accommodations for under $100 a night and if you happen to have a child with 
you, which we didn’t for our first cycle, but if you did and you didn’t know 
anybody well you’re looking at trying to find childcare in a strange city and pay 
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for that, which is not necessarily an easy feat either…Our medical costs for 2015 
were $25,000 out-of-pocket (Patient 7, urban, IUI and IVF, 1 child).  
 
Furthermore, a woman who is planning to access IVF this year after five failed IUI 
procedures and two miscarriages, described the substantial cost of leaving the province 
for service resulting from accommodations, food, and airfare. 
I definitely think it could be a lot cheaper if the [IVF] services were here 
because…we wouldn’t have the accommodations and we wouldn’t have the 
hotels and we wouldn’t have food and we wouldn’t have airfare so it would save 
us probably four or $5,000 for sure (Patient 11, urban, IUI, no children). 
 
The costs associated with out-of-province travel for IVF made it more difficult for 
patients to use this service. 
Partners working out-of-town or out-of-province also affected treatment cost. For 
one couple, the husband working out-of-town made IVF more expensive, as they were 
paying for multiple flights for each round of treatment. The patient, who travelled to 
Halifax for IVF, reported substantial flight costs in addition to the typical travel costs 
because her husband works outside NL. 
When we did up our income tax this year we had a $30,000 medical expense. It 
was like with travel to Halifax because we had to go there several times, my 
husband didn’t go for the [IVF] cycle with me, he flew there he left his sperm 
sample there cause he was going to be gone [for work], I flew back - my mom 
went with me - in August, so that was two flights there and then when that failed 
we were trying to figure out what’s going on so [my husband] needed…a sperm 
function analysis test…and they don’t do that here in Newfoundland so that was 
another trip back to Halifax…so then it’s hotels, meals, travel, car rentals…it cost 
a lot of initial money for the IVF that it’s just actually crazy the amount of money 
we’ve spent (Patient 10, urban, IUI and IVF, no children). 
 
The financial burden associated with fertility services is exacerbated in NL by 
time lost from work, geographical isolation of patients and distance from the fertility 
clinic, and the lack of IVF services in province.  
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4.3.1.1 Information about services and cost.  
Patients sought information from a variety of sources when researching fertility 
services. When they were asked about where they received their information about 
fertility treatment and cost, they mentioned Internet blogs, clinic websites, friends and 
family, family physicians, and fertility specialists and clinics. One patient said she got her 
information about procedures and costs from the clinic websites and that she “had a 
consultation with the doctor from Ontario and [that the doctor] went over all the costs and 
sent [her] an email on it as well” (Patient 11, urban, IUI, no children).  
4.3.1.2 Methods of payment and financial facilitators.  
Patients paid for the costs associated with their fertility treatment through a 
variety of methods, including out-of-pocket (with credit cards or lines of credit), private 
insurance, and family and friend contributions. The affordability of treatment was 
facilitated by wealth, low lab fees, MCP coverage, proximity to services, and family and 
friend financial and in-kind (place to stay) assistance to offset costs. Most patients could 
afford their treatment and related costs, or at least were able to pay for some of it out-of-
pocket. Private insurance coverage for fertility drugs also helped patients pay for 
treatment. The low cost of sperm washing and MCP coverage for the other aspects of IUI 
helped with the costs of locally available treatments. Many claimed their fertility-
associated costs on their income taxes. Some patients chose to take out loans in order to 
make the cost of their treatment more manageable. One woman with blocked fallopian 
tubes, whose husband did not have full-time, permanent work, reported using a line of 
credit to pay for IVF.  
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We just basically had no option and there was no point to try [IUI] in St. John’s, it 
wouldn’t work, my eggs can’t get down through my fallopian tubes, they’re so 
scarred. So we knew [IUI] was just wasting time and at the time I was 30 and I 
didn’t want to wait any longer. So we had no choice, we certainly didn’t have the 
money. We put it on a line of credit and just did it (Patient 1, rural, IVF, 1 child). 
 
Other patients were given money to help pay for their treatment by family and friends. 
For example, a woman who had three IUI and two IVF cycles said she received help 
from various family members. 
My mom and dad gave us a couple thousand dollars and one of my sisters had 
given me $2,000…and then when we went to Calgary my cousin had offered to 
pay for our flights… and when we were in Calgary [my husband’s] friend…was 
going on a family vacation for a couple of weeks so they actually offered us their 
home (Patient 10, urban, IUI and IVF, no children). 
 
Due to the substantial cost of fertility services, patients often employed multiple methods 
of payment in order to afford their treatment.  
4.3.2 Nature of fertility services and infertility.  
Patients reported having difficulty using services due to the number of times they 
needed to be at the clinic each cycle, the time sensitivity of the procedures, the low 
success rates for IUI, and treatment cycle cancellations. A patient’s experience with an 
IUI cycle cancellation was described by a woman when her cycle was cancelled after her 
estrogen levels were outside of the optimal range for a successful procedure. 
I remember everything was going good. I had taken the medications and 
everything, and then they did the blood work and there was something wrong with 
one of the levels, like my estrogen level was too low or too high or whatever. I 
remember the nurse called me and she said you know it’s just as well to cancel it 
like it’s not going to work… I just remember being so devastated (Patient 10, 
urban, IUI and IVF, no children). 
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This example shows how the variable nature of infertility and patient response to 
medication may lead to difficulty in using fertility services, as treatment cycles can be 
easily compromised.  
4.3.3 Physical environment.  
The weather in Newfoundland and Labrador also created challenges for some 
patients. A woman who lived a couple of hours outside of St. John’s found accessing 
services challenging, especially during the winter when storms are inevitable, due to the 
need to travel back and forth to the clinic. 
It is a pretty substantial drive, it’s almost 2 hours to get in [to the clinic]. So when 
we had to go in especially like winter you’d probably have to take a couple of 
days off work because if I had an appointment Friday [and] they were calling for 
any snow, I’d take Thursday off and then stay in St. John’s Thursday night just in 
case I couldn’t make my appointment. So I mean I don’t know how anybody 
would do it if they lived say on the west coast or something (Patient 5, rural, 
diagnostic services, 1 child). 
 
In this instance, the patient had to extend her trip because of bad weather. Her experience 
was made more difficult by the distance she lived from the fertility clinic, as she needed 
to come into St. John’s a day early to avoid a lengthy drive in a storm. 
4.3.4 Geography.  
Geography can pose an issue for patients, as the sole fertility clinic in the 
province is located on the east coast of Newfoundland in St. John’s. Few patients who 
were being treated at the local fertility clinic had to travel for treatment from areas that 
are geographically isolated or far from the clinic. An IUI patient from the west coast of 
Newfoundland stayed in St. John’s for a week during her treatment cycle to ensure that 
she could attend her appointments, saying “I was probably [at the clinic] three times for 
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the whole procedure but within [a] week” (Patient 4, rural, IUI and IVF, no children). As 
a result of the distance she lived from the clinic, she decided to stay in town and not 
return home between appointments.    
4.3.5 Lack of service availability.  
In addition to the issues associated with travelling in the province to access 
fertility services, many patients also have to travel out-of-province to access IVF 
services. A patient who accessed IVF in Halifax noted that residents of NL face 
additional challenges compared to other provinces when trying to access IVF, as they 
must fly in order to avail of the treatment. 
Right now there [are] two provinces that don’t offer IVF and that’s Newfoundland 
and PEI, but PEI has a bridge attached to another province that they can drive to 
(Patient 4, rural, IUI and IVF, no children). 
 
Another woman, who accessed IVF in Calgary, described the challenges associated with 
leaving the province for IVF and how these challenges make the service less accessible to 
residents of NL. She compared the NL case with people living in western Canada.  
I have numerous friends out in western Canada who have gone through this 
process and a lot of them just skipped IUI and went straight to IVF because there 
you go from your house to the clinic and it’s not this whole big thing of having to 
travel outside of the province. I mean yes, you still have to pay for the treatment 
but having to go somewhere where you’re not at your own home province it’s a 
big thing…When I went for my second cycle [my husband, son, and I] hopped in 
a plane and went out to Calgary. Then I had to take time off work [and] my 
husband had to take time off work. So it’s a very difficult [decision to make] 
because of the extra cost and logistics associated with having to travel out of 
province for the treatment (Patient 7, urban, IUI and IVF, 1 child). 
 
As this woman described, the out-of-province travel required for IVF makes the decision 
to use the service more difficult for patients.  
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4.4 Impact on Patients and Treatment Decisions 
Cost of treatment and travel, the nature of fertility services, NL’s weather and 
physical environment, the geographic location of the fertility clinic, and the lack of IVF 
services in NL not only create difficulty for patients using fertility services, but also have 
an impact on patient well-being and treatment decisions. 
4.4.1 Substituting IUI for IVF.  
Some participants chose to use IUI and to forego IVF altogether because they 
could not afford it. One patient, who did eight IUIs at the St. John’s clinic and is now 
pregnant, did not use IVF because of the financial challenges associated with leaving the 
province to have the procedure.  
When we had gone through I think it was about four IUI’s the clinic started 
bringing up the idea of IVF for us and leaving the province to have that done and 
as much as we would have liked to have done that, I mean financially it’s just not 
feasible for us (Patient 3, urban, IUI, pregnant).  
 
Similarly, another patient, who was a single woman in her forties buying sperm and 
having IUI, did not consider IVF because of the high cost. She is of low income, making 
the service unaffordable due to the cost of the procedure and associated travel. She said, 
“I would absolutely be interested in [IVF or other fertility procedures] except I would not 
be able to afford them…so yes, am I interested? Absolutely. Can I afford them? 
Absolutely not, completely inaccessible for my current financial situation” (Patient 9, 
urban, sperm purchasing and IUI, no children). 
Besides not being able to pay for IVF, patients were also motivated to opt for IUI 
because it is largely covered under MCP in NL. A woman from the west coast of 
Newfoundland began her fertility treatment with a round of IVF in Halifax, but then 
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chose to do IUI in St. John’s due to the cost of additional IVF procedures and MCP’s 
coverage of IUI. 
If we had the money obviously we would have done a second round of in vitro 
versus going for IUI because IUI is practically free [in NL] in comparison to in 
vitro… the only cost you have for IUI are the drugs which are minimal compared 
to IVF and the actual procedure itself is covered by MCP…so you’re just paying 
for your sperm washing…so it’s about 1,000 bucks versus [$15 000] (Patient 4, 
rural, IUI and IVF, no children). 
 
As a result of the high cost of IVF and the low cost of IUI in NL due to MCP 
coverage, many patients chose to use IUI over IVF, the provider described “gold 
standard” treatment. 
4.4.2 Delaying IVF.  
Participants not only chose IUI over IVF, but some chose to delay IVF and use 
IUI initially partly because they did not want to pay for IVF treatment and travel. For 
example, one patient started with six unsuccessful IUIs before deciding to access IVF 
treatments, which she noted was a decision heavily influenced by the cost of IVF 
treatment and travel. 
Obviously IVF had the highest likelihood of success but we knew we would have 
to go out of province to do that which has much more cost associated with it, so at 
that point we said let’s try IUI and see if it works…It was never a decision of can 
we do [IVF] or can’t we do it, it was can we do the lower cost option and get 
success, and it obviously would have prompted us to try [IUI] a little bit longer 
than had we not had to travel [for IVF] (Patient 7, urban, IUI and IVF, 1 child). 
 
Another patient from the St. John’s area had three unsuccessful IUIs at the local clinic 
before deciding to move on to IVF in Halifax, which was partly due to the cost of IVF 
treatment and travel. 
I knew it was going to cost a lot of money to go even to Halifax to have [IVF] 
done and that was another factor in the prolonging the IUIs it was just that I didn’t 
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want to go that route because you think oh God I could just come here and… pay 
$150 to the lab here to do the sperm washing…I mean $150 versus $10000. So 
the financial piece alone was huge in deciding to continue with IUI and not go the 
IVF route (Patient 10, urban, IUI and IVF, no children). 
 
Furthermore, one woman had intended to start with IVF instead of IUI because of the 
greater success rate. However, when she and her husband ran into trouble with house 
renovations, they decided to go with IUI because it was the cheaper option. 
IUI was costing us about $250 versus 12,000 [for IVF]…The doctor had 
recommended that IVF was probably a greater success rate than the IUI, so we 
were leaning towards going to do IVF, but with the house and the amount of 
money it cost we said well why not try [IUI] because we haven’t tried that at all 
and maybe it will work (Patient 11, urban, IUI, no children). 
 
After five failed IUI cycles, this woman was looking into IVF in Ottawa and Calgary at 
the time of her interview. The failed IUI cycles were emotionally damaging for her and 
she was taking time off of work. If she follows through with IVF, she will have to take 
days without pay from her job, pay additional money for treatment and travel, and face 
the possibility that IVF will not work either. The strategy of going with the cheaper 
treatment option to save money ended up costing patients more money and time in these 
cases, as they had multiple unsuccessful IUIs and then tried IVF. 
In contrast, some patients delayed IVF and were able to save money. According 
to a woman who used fertility services in St. John’s, the local fertility clinic recommends 
exhausting IUI before moving on to IVF, even though IVF is described (by providers) as 
the “gold standard” for fertility treatment. She said that IVF was not something she and 
her husband considered to be an immediate option due to the travel necessary to avail of 
the treatment. 
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In my mind there really is only IUI here so obviously IVF would be way down the 
line in terms of what we would consider and … [Dr. Y] said IVF is the gold 
standard, that would be our most successful option, but obviously because it’s not 
available here and because of the exorbitant cost of going away to get it that they 
would recommend exhausting the IUI options first (Patient 8, urban, medicated 
cycles, 1 child). 
 
This woman was able to have a child without using IVF and was able to save the money 
that would have been necessary for the treatment and travel. Additionally, a patient, who 
is now pregnant, had four IUI procedures and multiple cancelled cycles throughout 2015. 
She reported postponing IVF because of the need to leave the province and the costs that 
would result from out-of-province travel. She said “…if there was an IVF clinic here, 
[my husband and I] probably would have done IVF by June of [2015]” (Patient 6, urban, 
IUI, pregnant), rather than continuing with IUI and medicated cycles with timed 
intercourse until the end of the year. She was lucky enough to become pregnant and did 
not need to use IVF. This delay of IVF treatment would be less likely to occur if the 
service was available in NL. 
 Many patients reported delaying IVF in order to save money. However, some 
were more successful than others as not all women were able to become pregnant without 
using the provider described “gold standard” treatment. 
4.4.3 Site selection.  
When patients are making decisions about their fertility treatment and IVF, they 
must consider where they would like to go for IVF treatment. Some patients reported 
treatment and travel costs impacting where they chose to undergo IVF treatment. If 
patients had family or friends near a specific clinic, they might choose that clinic so they 
would have a place to stay and not have to pay for accommodations. For example, one 
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woman chose to travel to Calgary for IVF because she and her husband had previously 
lived there and could stay with friends, which would save them money. Her husband was 
also able to work thereby offsetting the financial burden substantially.  
[My husband and I] had a conversation around which clinic and because we spent 
time living in Calgary and my husband works for an oil [company] and would be 
able to work while we’re up there, we said let’s just go to Calgary. We can stay 
with friends and he can work while I’m doing appointments…I really didn’t look 
at other clinics because of the fact that we had accommodations in Calgary 
(Patient 7, urban, IUI and IVF, 1 child). 
 
Patients might also choose a specific clinic because closer locations would have 
lower flight costs. One patient chose to travel to Halifax for her first round of IVF 
because flights from St. John’s to Halifax are cheaper than to other locations (i.e., 
Calgary). The doctors had told her that the clinics would provide the same quality of 
service and that it did not matter which one she chose, so she and her husband chose 
Halifax: “Halifax was closer, it was going to cost [my husband and I] less to get there 
with flights and it was going to just be closer to home” (Patient 10, urban, IUI and IVF, 
no children). Social support, free accommodations, and low flight costs were some of the 
more frequently cited reasons for choosing one IVF clinic over another. 
 4.4.4 Stopping treatment.  
Financial challenges also forced patients to take a break from treatment or stop it 
altogether. Some patients reported that treatment and travel costs limited the number of 
times they could access treatment, and therefore the size of their family. One woman, 
who had a daughter through IVF and was taking a break from treatment, was unsure 
whether or not she would be able to have any more children using the procedure due to 
the substantial financial burden. 
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We’re very fortunate that we had one daughter… but it took us years to pay off 
the $12,000. Like I’m a teacher, my husband, he’s an electrician, he works odd 
jobs, so I mean we are a one income household for the most part. So it is very 
damaging financially. Now with the two frozen cycles that we did that had failed, 
you know that was around six or seven thousand, we’re still working to pay that 
off. So you know it’s a really big struggle in terms of deciding, you know, do we 
move ahead, do we go back again now and start all over from scratch and spend 
another $12,000 on a fresh cycle (Patient 1, rural, IVF, 1 child). 
 
This decision to take a break from treatment, or potentially end treatment altogether 
because of financial situations, was more commonly reported among IVF patients than 
among patients who stayed in NL for fertility care. 
4.4.5 No perceived barrier.  
Even though many women discussed the impact of financial barriers on their 
treatment decisions, there were some who said that treatment and travel costs were not 
enough to deter them from using fertility services. However, all of the women who said 
that cost did not prevent them from using fertility services were patients who accessed 
services only in St. John’s and lived within 50 km of the clinic. A patient who used IUI in 
St. John’s and did not have drug coverage, got pregnant on her third IUI. She said that 
“[cost] didn’t really matter…if it would end up in a child then fine” (Patient 2, urban, 
IUI, 2 children). Another patient accessed IUI at the local clinic and got pregnant after 
her fourth IUI. She was able to do whatever the doctors recommended in terms of 
treatment and drugs because of financial stability, although her insurance coverage for 
drugs was minimal.  
We were kind of just happy to follow what the doctors recommended, you know 
as much as we could. My husband has a really good job, so we were lucky that we 
could [afford the treatment because] the injectable drugs are really expensive too 
(Patient 6, urban, IUI, pregnant). 
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Additionally, a woman who had medicated treatment cycles, but no IUI, reported that the 
low cost of IUI in NL (due to MCP) would have allowed her to access services without 
restriction. 
IUI, luckily, is essentially covered [in NL]. You have to pay for the medications 
and I think like a $150 lab fee or something like that. So that really for us that was 
very minimal cost and wouldn’t have influenced how many cycles that we were 
able to do of it or anything like that (Patient 8, urban, medicated cycles, 1 child). 
 
 The cost associated with fertility treatment and travel was a factor that impacted 
treatment decisions for most patients, especially for those considering leaving the 
province for IVF. Only patients using IUI and living close to the St. John’s clinic claimed 
that the cost of treatment and travel did not play a role. 
4.4.6 Emotional impact.  
In addition to the financial challenges, many women also discussed emotional 
challenges, which resulted from infertility, failed procedures, and the financial cost 
associated with treatment. One patient, who took eight rounds of IUI to become pregnant, 
expressed concern about being able to continue with IUIs after her pregnancy due to the 
financial and emotional costs. She said, “I would love to have more kids than this but 
financially and emotionally I don’t know if it’s worth it…especially if my prescription 
drug coverage is up…I don’t know if it’s something that I will go for” (Patient 3, urban, 
IUI, pregnant). Another patient had diminished ovarian reserve, forcing her to use IVF 
technologies. After a successful IVF procedure, which gave her a son, and two 
unsuccessful procedures, she and her husband decided to stop trying for another child due 
to the financial and emotional challenges.  
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I mean after you spend that much time, effort, and money going through that 
process so many times, and especially given the infertility diagnosis that I have, it 
comes to a point where you just have to accept the diagnosis and move forward 
(Patient 7, urban, IUI and IVF, 1 child). 
 
This woman has reached a place of acceptance with her infertility after a success and 
multiple failures. For some women who have not had any success with fertility services, 
accepting their infertility is more difficult and continuing with treatment may be their 
only option. 
Some patients reported that financial stress resulting from treatment and travel 
costs worsened their already fragile emotional states. One woman, who had multiple 
failed IVF cycles, reported struggling emotionally throughout the duration of her 
treatments. The failed IVF cycles were even more devastating and disappointing due to 
the amount of money that was invested without success. 
I remember going in to see [Dr. X] and I asked if I could have a note for work and 
[Dr. X] said, ‘why are you off work’ and I said, ‘because I just went to Calgary 
and I invested all that money to try to get pregnant and I’m not pregnant’ (Patient 
10, urban, IUI and IVF, no children). 
 
Another patient, who has had five IUI cycles and is planning to avail of IVF, described 
her interpretation of the emotional cost of failed out-of-province IVF cycles. 
I haven’t gone to have IVF done, but I think if I did that and it was unsuccessful it 
would be very emotionally hard. It would be really stressful at that point and then 
having to decide to spend more money under more stress. I really think if the 
service was here it would save a lot of stress for people as well, it would do so 
much more than just save money (Patient 11, urban, IUI, no children). 
 
 Infertility and going through fertility treatments affected the women in this study 
not only financially, but also emotionally. The emotional costs of using fertility services 
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can often create additional challenges for patients making use of services that much more 
difficult.  
 These results represent patient experiences and opinions regarding the barriers to 
accessing fertility services in NL, but we must also consider the perspective of the service 
providers in order to have a more holistic view of the NL case. 
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5.0 Service Provider Study Results 
5.1 Description of Sample Population 
In this study, there were 11 fertility services staff members eligible to participate. 
Eight (72.7%) of the 11 completed interviews. The interviews lasted between 15 and 45 
minutes. There were five nurses (62.5%) and three physicians (37.5%) that participated. 
Service providers had an average of 9 years of experience working at NLFS. Limited 
service provider information is given to maintain participant confidentiality. 
5.2 Organization of Services  
Based on our interviews, we were able to gather information about the history of 
the clinic and the organization of services. The fertility services program started being 
offered in NL in 1997. The program was initially quite small, with only one physician 
and one nurse, and operating out of the Grace Hospital. Over the years, the demand for 
the service increased, as did the number of staff, and the program continued to expand, 
eventually moving to the Women’s Health Clinic in the Health Science Centre and then, 
with government funding, on to the Major’s Path clinic in 2006. The Major’s Path 
fertility clinic is currently the only one in NL, and therefore relies heavily on 
telemedicine and treating patients by distance to make service delivery available across 
the province.  
Most service providers who were interviewed described the services that are and 
are not offered by the fertility clinic. They said that the clinic has never been able to offer 
IVF and related services, including female fertility preservation, ICSI, and frozen embryo 
transfers. Additionally, gamete donation and purchasing is not offered locally and the 
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psychology program is underdeveloped because the psychologist is shared with the 
women’s health clinic. The service providers also noted that the clinic offers fertility 
assessment and diagnostic testing, tracking, medicated cycles, donor insemination, 
couple’s IUI, sperm banking for medical reasons, and prenatal care for high-risk fertility 
patients.  
 Clinic staff also described how the clinic compensates for limited service 
provision by satelliting with other clinics to make IVF services more accessible to 
residents. Satelliting means that patients can have their tracking and monitoring for IVF 
done in St. John’s, but they must travel to an IVF clinic out-of-province to actually 
receive the procedure. A service provider explained the role of NLFS in the treatment 
process for patients accessing IVF. 
We unfortunately don’t offer IVF to our patients, but we do refer them to clinics 
outside of the province and even outside of the country for IVF and donor egg, 
donor embryos, those type things. So we track those patients and help them with 
the referral process and then we follow up after their treatment, but we don’t 
actually provide [IVF] to our patients here (Service provider 2). 
 
This satelliting process helps patients because they do not need to leave the province for 
their entire treatment cycle, but rather just for the egg retrieval and IVF procedure. NLFS 
satellites with IVF clinics in Ottawa, Calgary, and Halifax, in particular. 
5.3 Patients Groups and Therapeutic Goals  
Staff reported that patients used fertility services to treat unexplained infertility, 
including inability to conceive or maintain a pregnancy, to preserve fertility, and to gain 
access to gametes. However, women and transgender men attempting to preserve their 
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fertility and people who are looking to access gametes face additional challenges because 
these services are not offered in NL and often not covered by provincial health insurance.  
5.4 MCP and Provincial Coverage Variation  
NL’s provincial health insurance, MCP, covers most aspects of fertility services 
that are offered within the province, except for the IUI lab fee for sperm washing. IVF 
services used by patients outside NL are not covered. One service provider described the 
fertility services covered under MCP:  
Everything else that we do here [besides medications] is covered under MCP like 
the ultrasounds, the blood work, the physician assessments, the nurse teaching - 
we have a nurse phone line - that’s all covered. Patients when they’re doing 
treatment cycles here will pay lab fees for sperm wash[ing] (Service provider 1). 
  
This level of coverage, however, is not universal across Canada. There is 
variation between provinces, as many staff members noted. Some provinces fund IUI, a 
round of IVF, or offer tax credits, while other provinces do not even cover infertility 
investigations. A service provider described the situation of a patient who had Alberta 
health insurance and had to pay the clinic in St. John’s for treatment that is covered under 
MCP. 
We have a patient right now that is an evacuee from Fort McMurray, so she 
would have Alberta Health, not MCP, [and it] just made sense for her to come 
back here. She’s in the middle of a cycle for IVF, so she needs some scanning 
done and we’re happy to do that for her, but…some provinces don’t cover that 
type of treatment (Service provider 2). 
 
According to a service provider, NL is better off in terms of public health insurance 
coverage than some other provinces. 
In Nova Scotia patients have to pay for investigations and things like that and 
when they start doing an IUI cycle they have to pay a lot more than you do in 
Newfoundland, because in Newfoundland the medical piece is covered but the lab 
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part is not. In Nova Scotia none of it is, so in Newfoundland we are better off than 
a lot of places for IVF or fertility treatment (Service provider 5). 
 
In addition to the variation among provincial health insurance plans, there are also 
differences in coverage among private insurance providers and plans. 
5.5 Variation in Private Coverage 
Most private health insurance plans often offer some level of fertility drug 
coverage, however this is not always the case. Some patients at the clinic have little or no 
fertility drug coverage. A service provider who had been at the clinic for years described 
the differences in private insurance fertility drug coverage. She also mentioned that some 
insurance plans might cover some of the travel costs as well. 
Some people [have] good drug plans, like the public service drug plan is about 
80% coverage [for fertility drugs] I think. Like military may have 100% coverage, 
but other people may have zero coverage in their health plans for their fertility 
drugs… Some people have some travel allowance in their individual health plans 
where it says that you can have up to $500 for travel for medical appointments. So 
we often provide notes to patients saying that we saw them on this day in clinic 
and they had to travel here because I guess they’re using that to go back to their 
insurance and say I had to travel (Service provider 5) 
 
Another service provider described the types of patients the clinic sees in terms of the 
level of drug coverage they have available through their insurance plans and what the 
level of coverage can mean for treatment. 
I would think 60% of people have pretty good coverage. Another 20% probably 
have okay coverage, but there’s a cap out amount, which is difficult for certain 
conditions where it requires a significant amount of [medication] and then what 
happens to a lot of our patients is sometimes they cap out before they even go to 
do IVF. Then there’s a group of people who have no insurance, so people who 
just either they have the type of jobs where you don’t have insurance or they’re 
lower income and they actually don’t have a lot of access to a lot of fertility 
treatments (Service provider 8). 
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Although there is coverage in many insurance plans for fertility drugs, there is usually not 
coverage for any fertility treatments. The exception to this, as reported by a provider at 
the clinic who has had discussions with patients about their insurance coverage, is some 
federal government employee insurance plans, such as the Royal Canadian Mounted 
Police (RCMP). 
RCMP will cover IVF if it’s the member’s problem. So if you have a male 
member [with] low sperm counts for example they’ll cover an IVF cycle for him, 
but if it’s a problem with the female partner they won’t cover the IVF cycle 
(Service provider 1). 
 
Differences between insurance plans make fertility services easier from some 
patients to use than others due to the cost of treatment.  
5.6 Types of Costs 
There are a variety of costs that residents of NL must incur when accessing 
fertility services other than costs directly associated with treatment. Treatment costs are 
dependent on the type and amount of treatment, as well as the type and amount of 
medication prescribed. For example, one service provider addressed the cost of IVF and 
how it increases based on the drugs required for the procedure and the patient’s 
condition, saying “An IVF cycle will cost you maybe in the neighbourhood of $10,000, 
for the IVF cycle and a reasonable number of drugs…[however] the drugs are dependent 
on other circumstances, the drugs may be way more than that” (Service provider 6). 
Another service provider described the cost of a frozen embryo transfer, which is cheaper 
than a full IVF procedure. The frozen embryo transfer is used to transfer a frozen embryo 
saved from a previous IVF cycle. 
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There is still the cost of going back and getting a transfer, but it’s significantly 
less. You’re just paying for the procedure, you’re not paying for the drugs to 
stimulate, you’re not paying for [an egg] retrieval, it’s just the transfer, which I 
think is probably $1,500/$2,000, very affordable compared to the $15,000 
(Service provider 2). 
 
The treatment and drug costs are often magnified by costs resulting from travel 
and its associated factors. Travelling for treatment often means paying for gas, rental 
cars, flights, accommodations, meals, and sometimes childcare, as well as losing time 
from work. The additional costs associated with travelling out-of-province for IVF were 
described by one service provider, who noted that these costs are somewhat unique to 
residents of NL. 
The IVF cycle itself is going to cost money, the drugs are going to cost money 
depending on your coverage that you have with your drug plan, but then there’s 
the travel on top of that. So it’s extra punitive for our patients. In addition to that 
they have to be away for up to 2 weeks at a time. So they’re off work, if you’re 
self-employed you’re not getting paid for those 2 weeks, and you have to find 
somewhere to stay, if you have friends or family excellent, if not you have to stay 
in a hotel for 2 weeks. That’s going to be extremely costly as well. So these are all 
extra costs, essentially punitive costs, for choosing to live in Newfoundland 
(Service provider 7). 
 
Another service provider described how not being able to offer IVF in the province 
impacts work loss for patients. If the treatments were available locally, patients would 
have to take much less time off from work. 
[If] we were doing IVF treatments here they’d probably only need 2 or 3 days off 
work. To go to an IVF clinic away they have to take about two weeks off, and a 
lot of the employers are actually not that accepting of it. I’ve had some patients 
that have been forced to take vacation to actually do their IVF cycle because it’s 
not deemed medically necessary (Service provider 8). 
 
 63 
 Both the direct and indirect costs of fertility treatment can be burdensome for 
patients. They often pay for treatment through multiple means in order to be able to 
afford it. 
5.7 Methods of Payment and Financial Assistance  
The clinic staff discussed a variety of ways that patients pay for treatment. 
Patients have paid out-of-pocket with a credit card, a line of credit or a loan, remortgaged 
their home, sold their car, accepted fundraised contributions or help from family and 
friends, used their private insurance coverage, and claimed their treatment and travel on 
their income tax return. A service provider mentioned that they have seen patients make 
decisions to fund their fertility treatment with enduring consequences. The provider said, 
“I’ve had patients of relatively low income that work with low-income jobs that take out 
debt and they’re in debt for [5 to 8] years to pay for what is essentially a recognized 
successful therapeutic intervention that’s just not covered” (Service provider 7). 
 The staff also described some of the conversations they have with patients about 
drug coverage, the cost of treatment, and their financial options. For example, one 
provider said that she tries to remind patients that the cost of having a child is much more 
than the cost of fertility drugs. She said she tells them “once [they] have a child the cost 
of having a child is probably not even comparable to the medication that would be 
prescribed if they were paying out-of-pocket, but it’s more of a perception and priorities” 
(Service provider 2). The same provider also discussed another conversation staff 
members have with patients related to their total budget for treatment and how their 
budget should influence their treatment decisions.  
 64 
We have this conversation with our patients, ‘how much money are you [going to] 
use towards IUI? If you are using up your 10,000 [dollar insurance] cap for just 
IUI with a 10 to 15% chance of getting pregnant each month, if you put that 
towards IVF and now your success rate goes up to 50% and you may end up there 
anyways’. Lots of times when you present [it] to them that way patients will move 
quicker to IVF (Service provider 2). 
 
Financial situations may often inhibit a patient’s ability to avail of a service, 
however clinic staff will still present all treatment options to the patient. One of the 
service providers described the conversation that clinic staff have with patients about IVF 
and that patients might not use the service due to financial situations. 
We have a discussion regarding is ‘doing more of these insemination cycles a 
futile endeavour?’ ‘Do we need to move on to the gold standard treatment, in 
vitro fertilization?’ A lot of patients will say ‘that’s just not something that’s 
financially viable for us’ (Service provider 7). 
 
Sometimes the staff may try to offer helpful tips to the patients. For example, a 
service provider mentioned that staff members tell patients to save receipts because they 
can claim the treatment on their income tax. The provider said, “We always tell [patients] 
going for in vitro fertilization to save [their] receipts because [they’re] able to use it as 
part of [their] medical expenses in [their] overall income tax and get some of the money 
back that way” (Service provider 4). 
Clinic staff will usually discuss financial matters with patients if they are related 
to treatment, however the conversations do not probe too deeply into patients’ financial 
situations. One service provider mentioned that the staff will have discussions with 
patients about their drug coverage and give them an information sheet to use when they 
talk to their insurance providers. However, the provider prefaced this by saying that she 
tries to stay out of patient finances. 
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My role as a [service provider] is not to discuss finances. It’s actually an 
uncomfortable job for [providers] to talk to people about their finances because 
our role is emotional support. So we don’t often, well hardly ever, discuss things 
like that. We may tell patients to check with their social worker or check with 
their drug plan and we give them a patient information sheet on that to see what 
their coverage actually is, but what’s actually covered [by insurance companies] I 
don’t know because we’ve never been taught that or told that information (Service 
provider 5). 
 
 What is said and not said to patients with regards to finances seems to be 
somewhat dependent on the individual staff member and is not a clinic-wide policy, as 
some providers are more comfortable than others offering their opinions and advice. 
5.8 Barriers to Accessing Fertility Services  
When asked about the challenges patients face when using fertility services in 
NL, staff noted many different factors. Those most commonly mentioned were cost, 
geography, and service availability, while the nature of fertility services, partner 
separation, social stigma, and gender were also mentioned. 
5.8.1 Cost.  
Some staff noted that the majority of patients using fertility services seem to be 
from middle to upper socioeconomic class. One service provider said that income limited 
the extent of treatment patients could access. She said, “We do see some in a lower socio-
economic group but they can’t go as far with treatments as some of the more affluent 
couples” (Service provider 1). She also noted that she thought people might not avail of 
services because they may not understand what is covered and they may believe they 
cannot afford them. Another service provider, while discussing the financial issues that 
some patients have, also mentioned that some people do not access service at all because 
they cannot afford it. She said, “There are all these other people out there that haven’t 
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even gotten through our doors cause they know they’re going to need help and they 
simply can’t afford it” (Service provider 2). The cost of fertility services makes it 
difficult for many patients to afford the services, specifically those of lower socio-
economic status. 
5.8.2 Geography.  
Besides financial circumstances, patients may also face challenges related to the 
distance they live from the fertility clinic. A service provider explained how geographical 
distance poses an issue for patients wishing to use fertility services because there is only 
one clinic in the province and patients must travel to receive treatment. 
The biggest barrier to access truth be told is geographic because it’s a sub-
specialized service, this is the only fertility clinic in Newfoundland. We’ve got 
adequate physician staff and nursing staff here, but it’s the only [clinic] in the 
province…anyone that needs our services oftentimes has to come here (Service 
provider 7). 
 
Patients travelling to access service experience more challenges than those who live close 
to the clinic. For example, a provider discussed the additional challenges for patients that 
live outside of St. John’s and surrounding areas, as they may miss multiple days from 
work each round of treatment. 
I think it makes a big difference if you can just take a late lunch break and come 
on over to the clinic for your appointment and only miss a few minutes of work 
versus having to take the whole day. We hear from school teachers all the time 
[who] live all around the province, it’s a big deal for them to take the whole day 
even though we provide them with a note and stuff because they may miss 2, 3, 4 
or more days per cycle just for their fertility treatments. So it’s a big commitment 
(Service provider 2). 
 
 For patients on the west coast of Newfoundland and from Labrador coming to St. 
John’s for fertility care is a long and expensive trip. According to one service provider, 
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these patients might choose to do IVF in Halifax before coming to St. John’s for IUI 
because the trips would be comparable. 
This is the only clinic in the province so we have some patients that might be in 
Labrador, some patients that are in Port-aux-Basques, it’s a long travel to come in 
to do an IUI cycle. Sometimes for example patients that are in Port-aux-Basques 
instead of travelling in here to do a cycle, like an IUI cycle, sometimes they opt to 
skip doing IUI’s and go straight to doing an IVF and go to Halifax because it’s 
almost closer in a way (Service provider 3). 
 
The distance that patients live from the fertility clinic makes a difference in the 
amount of difficulty they have when trying to use the services. However, this is not the 
only challenge that patients must face related to distance, as patients wishing to use IVF 
services must leave the province to do so.  
5.8.3 Lack of service availability.  
The lack of IVF services in the province was also an issue cited by the clinic staff. 
Without IVF technologies, patients must travel to access all IVF related treatment; this 
includes female fertility preservation, frozen embryo transfers, and ICSI (a more 
advanced IVF procedure). One service provider said that the lack of IVF services means 
that patients in NL do not have access to the most effective fertility treatment available. 
The lack of in vitro fertilization in the province [is] one of the biggest obstacles 
for fertility treatments because IVF truth be told is the gold standard for almost all 
forms of infertility whether it’s male factor, tubal disease, reduced ovarian 
reserve, whatever the case may be, unexplained infertility, that is the gold 
standard for a lot of it (Service provider 7). 
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Another service provider discussed the impact of not having egg preservation services 
available in NL, which affects women specifically6. Due to this disadvantage, some staff 
viewed gender as a barrier to equitable access to service.  
We rarely have any [cancer patients] that can actually avail [of fertility 
preservation] because when you’re staring down the barrel of cancer it’s kind of 
hard to take 2 weeks and go to another province and do egg freezing. So we’ve 
only had a couple people actually go and I think that’s something that we often 
don’t talk about in terms of not having an IVF clinic and what that means. I think 
not having IVF here is a real disservice to the women (Service provider 8). 
 
Access to gametes is also limited in the province, as gamete donation and 
purchasing services are not available. One of the clinic staff mentioned that not having 
access to gametes locally makes services more expensive and less accessible to patients. 
She said, “If someone is using a sperm donor, that is about $1,000 a cycle because they 
have to buy the sperm [and] get it shipped here because we don’t have a sperm bank here 
for that type of donor sperm” (Service provider 1). 
Not having certain services available in the province makes accessing these 
treatments more challenging for residents of NL than residents of most other provinces. 
Besides these three commonly cited barriers, there are some secondary challenges that 
also contribute to making fertility services difficult for patients to use. Some additional 
challenges worth noting are the nature of fertility services, partner separation, and the 
social stigma associated with infertility. 
                                                
6 Cryopreservation for sperm is available in NL for medical reasons (e.g., if a patient has 
testicular cancer and would like to preserve sperm) 
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5.8.4 Nature of fertility services.  
While some health programs offer travelling clinics in NL, the nature of fertility 
services prevents the provision of care across the province. The service is specialized 
with highly trained staff and equipment that is not portable, and patient cycles cannot be 
timed and scheduled. A service provider described the nature of fertility services and how 
that limits where services can be delivered.  
The perinatal program do what’s called travelling clinics. They go out and they 
visit and they see all their premature babies at 1 year old in Corner Brook. We 
can’t really do that because we only have one lab that has very specialized people 
that do this work, they’re all here. The equipment is all here, you can’t take it on 
the truck and go…and people’s cycles are very variable like you start people on 
fertility drugs and then on day 10 you bring them back in and you do an 
ultrasound, some of them are going be ready, some of them aren’t. So it’s not an 
easily timed procedure, you can’t just give someone an appointment for a 
particular day and stick with it. So it’s not possible or feasible to do it as a mobile 
service, so people have to come to you [and] that’s a big disadvantage (Service 
provider 5). 
 
The nature of fertility services means that patients must travel to the fertility clinic in 
order to receive treatment. 
5.8.5 Partner separation.  
In NL, partners may often work out-of-province or in offshore oil drilling, which 
limits the amount of time a couple has together and their chances of becoming pregnant. 
It also makes timing cycles through fertility services more difficult. Many of the staff 
mentioned partners working away as a barrier to women becoming pregnant on their 
own, but also to accessing fertility services. Timing treatment with the partner being 
home and ovulation can be difficult. One service provider described “the issue of the 
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partner that works away” and how that prevents patients from being able to access 
services or achieve pregnancy through the use of fertility services.  
There’s the issue of the partner that works away…sometimes both of them work 
away or the husband or the wife works in the oil patch or offshore and physically 
getting them [to the clinic] is hard. Then things are so dependent on their cycle 
and timing that they just can’t make it work (Service provider 2). 
 
Another service provider mentioned that having partners working away from home 
prevents the staff from being able to schedule back-to-back cycles, which will prolong 
the process of trying to get pregnant. The provider said, “In Newfoundland we have a lot 
of people working away which impacts our ability to allow them to do continual [IUI] 
cycles” (Service provider 8). Partners who work away from home create additional 
challenges for those who wish to use fertility services, as service providers struggle to 
coordinate treatment plans that fit with their schedules. These challenges are exacerbated 
by the lack of cryopreservation services. 
 5.8.6 Social stigma.  
The stigma surrounding infertility also makes it difficult for patients to avail of 
fertility services. Many people see infertility as a private matter and do not want others 
knowing that they are being treated through the fertility clinic. According to one service 
provider, some patients create their own barriers because of the social stigma. 
People create their own barriers because they don’t want to tell somebody that 
they’re infertile or they’re having trouble getting pregnant. They don’t want to 
share that. So they probably aren’t going to tell their employer and so their 
employer thinks oh this person is taking a lot of sick leave they were just gone to 
St. John’s for the long weekend…So they’re often isolated in terms of support I 
guess. Sometimes their families don’t even know because they’re very private and 
don’t want to share. Even when people come into the clinic they’re afraid 
someone is going to see them from their community and they don’t want other 
people to know that they’re having trouble getting pregnant (Service provider 5). 
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Social stigma can worsen a patient’s experience with infertility and fertility care, as they 
may feel that their condition is private. It is just one of the challenges that patients may 
face when being treated for infertility and is particularly relevant in a community-centric 
province, such as NL.  
 The challenges described above create both service provider and patient driven 
responses. The service provider responses will be described in the following section (5.9) 
and patient responses will be described in sections 5.10 and 5.11. 
5.9 Service Provider Responses to Barriers 
In NL, geography and service availability are relatively unique challenges 
associated with using fertility services and tend to exacerbate the financial burden. These 
factors often have an impact on how service providers treat their patients. Health care 
teams try to make the services as affordable and geographically close to patients as 
possible. Some of the ways in which they alter standard treatment plans are by changing 
drug protocols, manipulating ovulation, offering consultations by telemedicine, and 
minimizing clinic visits for patients. 
5.9.1 Changing drug protocols.  
Sometimes physicians will opt for a cheaper drug regimen to help patients who do 
not have insurance. For example, one service provider described what a conversation 
with a patient without insurance would look like and how they would alter that patient’s 
drug protocol.  
I will say, ‘look you’ve got no insurance, let’s maximize what we can do with the 
oral pills instead of just adding the injections that are way way more expensive’. 
 72 
Maybe I’d push that a little bit further in a patient with no insurance than I would 
if she had the insurance I might have moved on quicker (Service provider 6). 
 
Prescribing cheaper medication for a patient without insurance is not the only way that 
physicians may alter drug protocols. According to a service provider, physicians will 
prescribe different drugs to better accommodate a patient’s specific coverage under their 
health insurance plan.  
If [physicians] know somebody doesn’t have drug coverage, [they] will try to 
change it to a drug that they actually have coverage for which may or may not 
impact on their success rate sometimes. [We] try to delay using injectable drugs if 
[we] can but sometimes that’s not in the best interest of the patient, so if they can 
afford the injectable drugs [we] try to encourage it (Service provider 8). 
 
Changing drug protocols in these ways to better suit a patient’s financial situation and 
drug coverage helps make fertility treatment more affordable. 
5.9.2 Manipulating ovulation.  
Another way the clinic staff members make changes to a patient’s treatment is by 
manipulating menstrual cycles. In situations where a patient or their partner works away 
from home, the clinic will try to ensure that the patient is ovulating at the same time that 
they or their partner are home and receiving treatment. This is done through the use of 
birth control pills. The process of timing fertility with birth control was described by one 
of the clinic staff. 
For the women or men whose partners aren’t working here we can use birth 
control pills and things like that to try to sync them up. So we do things to help 
manipulate the [woman’s] cycle so they can actually be around each other when 
they’re actually in a fertile period of time. So that involves a lot of nursing time 
and nursing conversation and timing things with the patient (Service provider 8). 
 
Making sure that a patient is fertile while she and her partner are together is one 
way that treatment plans can be altered to optimize the chance for pregnancy.  
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5.9.3 Teleconsultations.  
NLFS provides teleconsultations to compensate for geographical challenges and 
bring fertility care to rural and remote areas of the province, specifically central and 
western NL. One service provider explained how the clinic tries to make fertility services 
more accessible for patients across the province through telemedicine. 
We’re in the northeast Avalon and everybody else is a thousand kilometers or 
more away, so we’ve tried to make access better for patients by telemedicine. So 
we do some telehealth where we can do video conferencing and see patients that 
way (Service provider 5). 
 
Another service provider mentioned that they were holding teleconsultations, rather than 
making patients travel to St. John’s unnecessarily, on the same day as their interview. 
We try to provide telemedicine appointments for patients that live far away. So 
that’s where I was this afternoon I was actually doing a telemedicine clinic and I 
saw a variety of people from Labrador to Grand Falls [to] Corner Brook. So I saw 
people all across the province so that they don’t have to come to St. John’s just to 
see us because for most of it it’s a history taking thing (Service provider 8). 
 
Teleconsultations are another way that the fertility clinic alters traditional service 
delivery to minimize the challenges patients face due to geographical isolation.  
5.9.4 Minimizing clinic visits.  
Another way in which the clinic tries to make fertility services more accessible 
for patients in rural and remote regions is by working with health care teams across the 
province in order to minimize patient visits to St. John’s when possible. They can offer 
blood tests instead of ultrasounds to these patients to determine whether or not the patient 
can begin a treatment cycle. For example, one service provider discussed how the clinic 
would handle a patient from Corner Brook. The patient would have blood work done in 
her hometown rather than driving across Newfoundland to St. John’s for an ultrasound. 
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So if someone was in Corner Brook instead of coming here on day 3 for their 
ultrasound to start this treatment cycle, we’ll do blood work in Corner Brook and 
have them fax that to us, so that’s what we call that distance cycle so that’s one 
way we can do it, it’s not as good as seeing them here but it’s an acceptable 
substitute (Service provider 1). 
 
Another service provider explained how the blood work would indicate if there was a 
cyst and whether the patient could proceed with treatment, again noting that the blood 
work was not the best level of care in this situation. 
What we do are distant [estradiol blood tests], so blood work that they can get 
done [close to home] and usually if the estradiol is low they don’t have a cyst and 
they can start a cycle, but that’s secondary care, that’s not the gold standard. The 
gold standard is the ultrasound. So already we wonder is their cycle compromised 
because we’re already starting out in less than ideal circumstances because 
physically the patient couldn’t get in her car and drive 8 hours for a 15 minute 
appointment (Service provider 2). 
 
Additionally, a service provider elaborated on this process and how “patients at a 
distance” differ from patients living east of Clarenville (within 150 or 200 km of the 
clinic). 
“Patients at a distance” sometimes will do blood work instead of doing 
ultrasounds…What we’re looking to see is that there isn’t a cyst in the ovaries and 
you can check the estrogen in the blood to see that. Obviously the best test is to do 
an ultrasound, but if you live in Corner Brook or Labrador and it means one extra 
trip in here for that, we’ll probably do a secondary test, which is a blood test, 
which is easy [and] you can get done in your hometown. So we do modify plans 
and we actually call those “patients at a distance” cycles and they are different 
than patients that live in the St. John’s area or the greater St. John’s area, you 
know like [Conception Bay South] and Carbonear and those areas, like all those 
patients anywhere really east of Clarenville would probably come in for those 
tests rather than have the blood test (Service provider 5). 
 
Most of the clinic staff noted that the blood test was not as good as an ultrasound, but 
given the distance the patients would have to travel to get to the clinic, it sufficed as a 
substitute.  
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5.10 Impact on Patient Decision-Making.  
The barriers to accessing fertility services not only affect how health care 
providers deliver care, but also impact patient treatment decisions. According to clinic 
staff, financial burden has the largest effect on patient decision-making. The cost of 
treatment and travel can affect patient treatment decisions in a number of ways, including 
patients choosing cheaper drugs, delaying IVF, not using IVF, opting to transfer multiple 
embryos, and stopping treatment. 
 5.10.1 Choosing cheaper drugs.  
Patients may opt for cheaper drugs if they feel that they do not have the financial 
means to afford the more effective and expensive medications. One service provider 
described the situation of a patient who exhausted her drug coverage, could no longer 
afford medications that stimulate oocyte production, and was back to using oral 
medications for ovulation induction (oocyte release) even though the clinic staff thought 
it to be futile.  
This one particular patient her insurance is gone, done. So she’s gone back to 
using oral medication, she did not stimulate. She’s had probably three or four 
blood draws now to check her estradiol [because] she lives out in central 
[Newfoundland], so [it’s] not feasible for her to come [to St. John’s] all the time 
[for an ultrasound]. We know there’s no point [because] she’s not stimulating at 
all for the oral meds. So there’s really was no purpose in her doing a cycle at all, 
but she felt she needed to do something and she wanted to take the chance that 
maybe it would work and it did not (Service provider 2). 
 
Without insurance, patients may not be able to afford medications that optimize their 
chance for a successful treatment cycle. Choosing cheaper drugs is just one way that 
patients try to minimize their treatment costs. 
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5.10.2 Delaying IVF.  
Besides choosing cheaper drugs, patients may also choose to delay IVF treatment 
to avoid the cost associated with treatment and travel. Most commonly patients will 
choose to do IUI longer than clinic staff advises because it is cheaper. A service provider 
explained this situation where patients opt for additional cycles of IUI beyond what has 
been advised by their health care team because they consider it to be more affordable. 
If we were in a province that had in vitro fertilization patients would probably do 
one to two cycles of insemination and then move very quickly to IVF. [Since] 
IVF is not offered here patients will often do many more cycles of insemination 
hoping that they’re going to get pregnant and they won’t have to foot the big bill 
of going for IVF and having to travel outside the province and all that kind of 
stuff. So they kind of stay in that first stage of care longer than they would in 
other provinces [that offer IVF] (Service provider 4). 
 
5.10.3 Not using IVF.  
Some patients cannot afford to use IVF services at all. Without IVF being 
available in NL, these services are out-of-reach financially and geographically to many of 
the province’s residents. The clinic staff normally recommends that patients try IVF after 
six to eight cycles of IUI, however some patients do not consider IVF to be a financially 
feasible option. 
What we do here if [a patient hasn’t] gotten pregnant within six to eight cycles of 
IUI, in addition to the time they were trying to get pregnant on their own, it’s 
unlikely to happen. So we have a discussion regarding is doing more of these 
insemination cycles a futile endeavour, do we need to move on to the gold 
standard treatment, in vitro fertilization, and a lot of patients will say that’s just 
not something that’s financially viable for [them] (Service provider 7). 
 
5.10.3.1 Women with cancer are particularly affected.  
Women who require fertility preservation after a cancer diagnosis are particularly 
affected by the lack of IVF in NL. This service provider described what a conversation 
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with a woman in this situation normally looks like. The provider tells them that they 
would have to travel, spend a substantial amount of money, and be away from their 
friends and family in order to preserve their fertility. Most women cannot handle all of 
this on top of their cancer diagnosis and therefore do not use the treatment. 
I have this discussion with patients. [I] say, ‘yes, you know you’re dealing with 
[a] cancer diagnosis, you’ve been sent here to have a discussion regarding fertility 
preservation. Is there something we can do to preserve your fertility to help you 
have genetic offspring? Absolutely, yes there is. It’s of proven benefit, it’s been 
around for years…but it’s not covered by MCP. So you have to pay for it yourself 
[and] you have to do it in the next 2 weeks. So you need to scrounge up $15,000 
to do this within the next 2 weeks. Also, while you’re dealing with [a] new cancer 
diagnosis you’re going to get dragged away from your support system, if you 
have the money to do this. [You’re] going to fly away to the IVF clinic that’s out 
of province, where you don’t know anybody, don’t have any friends, don’t have 
any family, and you’re going through this stressful cancer diagnosis, stressful 
fertility treatments, and we’ll send you off to do that’. Most patients truth be told 
just don’t have it with them to do it, they can’t deal with all of that at the same 
time (Service provider 7). 
 
Not having IVF in the province also means that patients are more likely to take 
extraordinary measures to try to ensure pregnancy if they leave the province to receive 
the treatment. 
5.10.4 Opting to transfer multiple embryos.  
The high cost associated with using fertility services makes patients more likely to 
transfer multiple embryos and risk multiple pregnancies because of their financial 
commitments. Health care teams will avoid transferring multiple embryos and over 
stimulating a patient in order to minimize the risk of a multiple pregnancy because 
multiple pregnancies can be dangerous for both the mother and foetuses. According to 
one service provider, some patients that go away for IVF will have multiple embryos 
transferred, even though most health care teams recommend transferring one embryo. 
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Usually as a rule of thumb [they] only transfer back one [embryo]. A lot of our 
patients will opt for two even though that’s not the recommendation, but they feel 
like they’ve travelled, they put all this money into it, [and] it’s hugely 
inconvenient to go back. So they’re willing to take the risk of multiples, which is 
not really advisable, but I can see why the patients do that (Service provider 2). 
 
Another service provider noted that if the service was available here patients might be 
more likely to transfer one embryo. 
Oftentimes when patients would go away for IVF sometimes they would put in 
two embryos for example instead of one because it’s not so easy for them to go 
back for a second IVF cycle because of the expense and geographics [sic] of it 
all… So then they would be at higher risk for having twins as opposed to if [IVF] 
was here then maybe they would have just transferred the one embryo (Service 
provider 3). 
 
Additionally, a service provider said that clinics will recommend transferring one embryo 
to minimize the risk of multiple pregnancy, but that the patient has some say in the 
number that are transferred because they own the embryos. The provider noted that the 
financial investment pushes patients to choose more dangerous approaches. 
The fertility clinic would say, ‘listen we should put one embryo in here to 
minimize the risk of multiple pregnancy and the complications that are associated 
with that’…[but] the patient says, ‘I want to put in as many embryos as you will 
put in’. Most clinics will say, ‘the most we’ll do is two’, every now and then 
someone might put in three under extreme circumstances, but [the financial 
investment] does drive the patient to [take] a bit more of a riskier approach to 
things (Service provider 7). 
 
5.10.5 Stopping treatment.  
Another way in which patient treatment decisions are impacted by financial 
challenges is that sometimes patients will choose to stop treatment altogether. One 
service provider told the story of a couple from central Newfoundland who stopped doing 
fertility treatment because they had to choose between a kitchen renovation or continuing 
with treatment because they could not afford both. 
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We have one particular couple from central and they weren’t on the same page. 
She was very keen to continue with treatment which was costly because they were 
using injectables for a long period of time to get a stimulation, but he actually said 
this: ‘a $10,000 renovation on the kitchen or continued [IUI] treatment’. They 
already have a child. His perception is that why are we putting money into 
something that’s probably not going to work. The woman was very keen to just 
continue treatment, but he saw that there was a limited amount of money and [that 
they were] either going to do the renovation or [were] going to continue to try to 
have another child (Service provider 2). 
 
Another service provider said that sometimes patients stop treatment because they cannot 
afford to take on more debt. 
I’ve seen a lot of patients that have just kind of given up hope for it. A lot of 
people might already have some debt, whether it’s home debt, vehicle debt, 
education debt, and they say ‘can I afford to take on even more’. A lot of patients 
just say ‘it’s not something that’s an option for us’. I see that not infrequently, 
they just give up on it (Service provider 7). 
 
Cost is something that patients must consider before choosing to use fertility 
services, and at times may affect their treatment decisions, specifically preventing them 
from continuing with treatment.  
5.11 Impact on Patient Well-Being 
Patients are emotionally affected by their fertility care as well. They tend to 
experience grief, desperation, isolation, and often feel as though they are treated unfairly.  
5.11.1 Grief.  
Many staff members talked about the emotional cost of accessing fertility 
treatment and the resiliency of the patients. Fertility patients are faced with 
disappointment and grief with every failed treatment cycle. For example, a service 
provider described the resiliency of patients by telling the story of a specific patient who 
had multiple pregnancy losses and is still undergoing fertility treatment. 
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I’m amazed at how resilient some of these patients are…the extent that some of 
the patients are willing to go to have a family. I mean [I know a patient] that had a 
still birth…another loss at [5 months], and…other early miscarriages and she’s 
still willing to go through the process. I mean tough as nails right, but it’s hard to 
go through that emotionally. It’s a huge time commitment, it’s a huge financial 
commitment, but even more so it’s a huge emotional commitment. My God the 
stuff that these women go through it’s unreal (Service provider 7). 
 
Another service provider compared infertility to cancer, saying that it is extremely 
difficult emotionally for patients and that they are willing to do what it takes to have a 
child. 
A lot of people think if you can’t have a baby it’s not a big deal, but for some of 
these people it’s no different than having cancer. I mean it is different, but 
emotionally it’s a very difficult thing and if there was a treatment that you knew 
could possibly cure your cancer you’d probably take that expense and I think that 
that’s the mindset of a lot of people (Service provider 8). 
 
The patient experience of being treated for infertility is often emotionally difficult, as 
patients will experience a lot of stress, grief, and disappointment from rigorous and 
unsuccessful treatment cycles. 
5.11.2 Desperation.  
Due to the emotional and financial toll that fertility treatment takes, patients are 
more likely to make decisions out of desperation. One participant told the story of a 
patient from the west coast of Newfoundland who was receiving IUI treatments in St. 
John’s and triggered herself (for ovulation) in order to speed up her treatment so she 
would be able to return home and to work sooner. 
We always scan our patient before insemination to make sure if they’ve taken 
medication that they didn’t over stimulate because we don’t want to wind up with 
multiples. So we need to know how many follicles are there and [this] patient was 
feeling a lot of pressure to get her insemination done on the weekend and she 
came in for her ultrasound. She wasn’t ready and we sent her to get blood work 
done and she came back tearful in a few minutes because she didn’t let on in her 
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appointment that they wanted to get back home before Monday so she had gone 
ahead and triggered herself thinking that was going to speed it up. Well in fact 
what we were seeing on the ultrasound was that she had already ovulated. We 
didn’t know she had done that. It didn’t fit the whole picture, which is why we 
sent her for blood work. That’s how desperate the patient felt, to take it upon 
herself to give a medication to herself, a needle an injection that was not ordered 
yet and ended up sabotaging an entire cycle (Service provider 2). 
 
A service provider described a similar situation where a patient took more drugs than the 
health care team had prescribed, so they told her to not continue with the cycle to avoid 
multiple pregnancies. The patient triggered herself and had intercourse anyway hoping to 
get pregnant, which could have had serious consequences. 
I know of one patient that gave herself more drug than we prescribed, we advised 
her against continuing with the cycle and against triggering herself to make 
herself ovulate and she should contracept when she does ovulate to avoid the risk 
of pregnancy, so she definitely took her own trigger shot when she went home 
and she had intercourse at home in the hopes of conceiving a pregnancy and that 
she could have easily had quadruplets out of that. At that point in time she says, ‘I 
don’t care if I have four babies, I just want a baby’ (Service provider 7). 
 
Many fertility patients experience this desperation for successful treatment, especially 
after multiple failed treatment cycles, which can have a serious impact on patient well-
being.  
5.11.3 Isolation.  
Patients may also feel isolated during their treatment. For example, one service 
provider described how sending patients away for IVF is emotionally draining because 
the patients are separated from their support systems. 
You’re taking [IVF patients] out of their environment. So they’re not around their 
circle of support and so psychologically it can be pretty draining for those 
patients. It’s very isolating because they have to leave their family and all their 
friends to go do IVF (Service provider 8). 
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This separation from social support systems is emotionally costly for patients that must 
leave the province to avail of IVF and makes fertility treatments even more difficult. 
5.11.4 Injustice.  
Patients and service providers often feel that it is unfair that patients have to pay 
to use fertility services. According to a service provider, patients are penalized financially 
for their infertility. 
If you’re infertile you’re penalized [because] you have to financially pay to grow 
your family… if you viewed it as a medical problem and the only treatment or 
cure was a baby then why isn’t it covered (Service provider 2). 
 
Another service provider at the clinic compared infertility to smoking, saying that 
smokers choose to smoke and their treatment is covered, but people who are infertile do 
not choose to be and have to pay for treatment. The provider then compared infertility 
treatment to hip replacements, as both are related to quality of life, questioning why 
patients do not pay for hip replacements, but pay for infertility treatment.  
You can smoke all your life and have your third heart surgery and it’s covered, 
but through no fault of your own you just don’t get pregnant and don’t have 
babies and that’s singled out as something that’s not covered. Then when they say 
well it’s not life threatening. Well then neither is a bad hip, but the prosthesis is 
something like $6,000 and of course you’re going to need another one. So that’s 
[$12,000] and that’s just the piece of hardware that’s not the surgery or anything 
else. So I mean when you’re trying to cover something that’s a quality of life 
situation as opposed to life threatening…[Having children is] an innate right 
(Service provider 6). 
 
The specific issues IVF access, both financially and geographically, were also considered 
to be unfair for patients. One participant noted this lack of fairness in terms of not having 
access to IVF in NL and having to pay for it out-of-pocket. 
Not having access to a treatment that is proven to be of benefit to patients, of 
proven success for patients, and to have to pay out-of-pocket for that and not have 
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access to it in your own province with your own support network is really unfair 
(Service provider 7). 
 
Service providers and patients both felt as though fertility services should be considered 
medically necessary and covered under provincial health plans, as the financial burden 
has a serious impact on patient quality of life. 
The challenges that patients face when accessing fertility services have an effect 
on patient well-being and treatment decisions, as shown through the service provider 
interviews. They also affect how patients are treated from the perspective of the health 
care team. These barriers to service access create immediate challenges for patients, but 
also have a long-lasting impact in other areas of their lives. 
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6.0 Discussion 
In NL, accessing fertility services presents unique challenges for the province’s 
residents. This project used interviews with patients and service providers to explore the 
barriers that patients face when using fertility services in NL and how these barriers 
impact treatment decisions.  
6.1 Overview of Conceptual Framework 
 Through the interviews, a conceptual model emerged that describes the 
combination of three factors: patient groups, therapeutic goals, and barriers (Figure 6.1). 
These factors collectively influence the impact on fertility treatment. The model explains 
how different patient groups, when seeking specific therapeutic goals, will experience 
different types of barriers that contribute to decisions about treatment. 
 
 
Figure 6.1. General model for conceptual framework demonstrating the relationship 
between patient group, therapeutic goal, barriers, and impact on treatment.  
 
This figure illustrates the relationship between barriers, patient groups, 
therapeutic goals, and impacts on treatment. Although there were a number of barriers, 
patient groups, therapeutic goals, and impacts identified, this thesis largely explored 
barriers and impacts for heterosexual women (in couples) looking to become pregnant 
Patient	Group	 Therapeutic	Goal	 Barrier	 Impact	on	Treatment	
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(Figure 6.2). However, the data also identified other patient groups, alternate therapeutic 
goals, and barriers that may be relevant to only these patient groups or goals. A specific 
example based on this model is as follows: a heterosexual couple whose therapeutic goal 
is to become pregnant may face financial barriers that may force them to stop fertility 
treatment.  
 
 
Figure 6.2. Conceptual framework demonstrating the relationship between barriers to 
accessing fertility treatment and impacts on treatment for heterosexual women (in 
couples) looking to become pregnant. 
 
This figure illustrates the factors that were discussed and focused on in this 
research. This is a comprehensive list of barriers and impacts for heterosexual women (in 
couples) with the goal of having a baby, however the barriers and treatment impacts for 
other patient groups with other therapeutic goals have not been explored in this research. 
Barriers		-	Cost		-	Service	availability		-	Geography		-	Nature	of	services	-	Partner	separation	-	Social	stigma	
Patient	Groups		-	Single	people		-	Same-sex	couples		-	Heterosexual	women	(in	couples)		-	Transgender	people		-	Cancer	patients		
Therapeutic	Goals		-	Pregnancy	(and	live	birth)		-	Preserve	fertility	
Impact	on	Treatment	Patient	responses		-	Substitute	IUI/no	IVF		-	Delay	IVF		-	Site	selection		-	Stop	treatment		-	No	impact		-	Choose	cheaper	drugs		-	Implant	multiple	embryos	Provider	responses		-	Change	drug	protocols		-	Minimize	clinic	visits		-	Teleconsultations		-	Manipulate	ovulation	
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6.2 Patient Groups 
Although heterosexual women (in couples) unable to achieve or maintain a 
pregnancy were the main patient group examined in this project, other groups were also 
identified including single women, same-sex couples, cancer patients, and transgender 
individuals. Many studies currently frame infertility from the perspective of heterosexual 
couples (Bushnik et al., 2012; Collins et al., 1997; Gurunath et al., 2011) and neglect 
these other patient groups. The World Health Organization also defines infertility in a 
heteronormative manner, as a period of time in which a woman having regular 
unprotected sex fails to become pregnant (Zegers-Hochschild et al., 2009). Jin and 
Dasgupta (2016) reviewed fertility centre websites and found that patient education was 
heavily focused towards heterosexual couples and did not provide similar information for 
Lesbian, Gay, Bisexual, and Transgender (LGBT) couples or individuals. 
Some recent studies have begun to examine infertility from the perspective of 
other patient groups; in particular, cancer patients looking to preserve their fertility have 
been the focus of recent studies. Yee (2016) surveyed 188 Canadian women between the 
ages of 18-39 who had been through cancer treatment. The study found that 76% of 
patients had discussions with their oncologists regarding fertility preservation, 26% of the 
women consulted a fertility specialist, and 9% underwent fertility preservation. For 
transgender patients, fertility preservation services seem to be underutilized, especially 
for female-to-male patients (Jones, Reiter, & Greenblatt, 2016), who must undergo more 
expensive and invasive procedures. 
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Even though research is beginning to consider other patient groups using fertility 
services, these groups are still generally overlooked when discussing infertility and 
associated issues. Examining infertility, prevalence, and fertility service uptake among 
the many patient groups identified in this study should be an area for future research and 
will hopefully continue to broaden the health and research communities’ ideas of 
infertility.   
6.3 Therapeutic Goals 
 Therapeutic goals also determine how barriers affect treatment. Patients and 
providers described two main reasons for patients using fertility services: to become 
pregnant and to preserve fertility. These reasons for treatment are similar to those 
reported in the literature, as multiple studies discuss patients looking to become pregnant 
(Domar & Gordon, 2011; Veltman-Verhulst et al., 2016) and preserve their fertility 
(Jones et al., 2016; Yee, 2016). These therapeutic goals, along with barriers to accessing 
treatment and patient group, create varying impacts on treatment decisions from both the 
provider and patient perspectives. The impacts that were uncovered in this research are 
based on the barriers faced by heterosexual women (in couples) with the goal of having a 
baby from the perspective of female patients and service providers. Further research 
should explore the barriers associated with these alternative therapeutic goals, such as 
fertility preservation, for other patient groups. 
6.4 Barriers to Treatment 
Patients and service providers similarly described barriers to treatment. Both 
groups reported costs associated with accessing fertility services, geography, lack of 
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service availability, and the nature of fertility services as challenges that patients face 
when being treated for infertility. As stated in the study expectations, patients faced 
financial and geographical challenges that affected their ability to access fertility services. 
In addition, interview participants described additional factors, like stigma and partner 
separation, that we had not anticipated. 
6.4.1 Costs.  
Costs were generally described in financial terms, however there were other costs 
uncovered through this study, including opportunity and emotional costs. Financial costs 
are straightforward, monetary payments for treatment received. Opportunity costs are lost 
opportunities due to time or money needed for treatment. Emotional costs are related to 
the emotional burden of infertility and undergoing fertility treatment. 
 6.4.1.1 Financial.  
Financial costs were most commonly cited by patients and service providers. 
These costs included treatment, drugs, travel, accommodations, and loss of pay from time 
off work. The financial costs described did not vary between patient and provider groups. 
These financial challenges are well documented throughout infertility literature, as 
patients have cited treatment costs (Akyuz & Sever, 2009; McDowell & Murray, 2011), 
drug costs (Makuch et al., 2011), travel costs, and loss of income (Redshaw et al., 2007) 
as barriers to accessing treatment. The costs reported in this study by patients and 
providers were also similar to those reported by cancer patients in NL in Mathews, 
Buehler, and West (2009) and Mathews, West, and Buehler (2009), as both studies found 
travel, lodging, drugs, and loss of income to impact financial costs. Rural cancer 
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survivors from northern British Colombia experienced difficulty accessing medical and 
support services due to travel and the associated costs (Fuchsia Howard et al., 2014). 
When hemodialysis patients did not have to travel for treatment and were able to receive 
treatment in their own communities, they had lower overall costs, better outcomes, and 
higher quality of life (Diamant et al., 2010). In general, travel related costs created 
challenges for many different patients. 
Service providers thought that patients of low socioeconomic status were 
particularly affected by cost, as they would not seek out fertility services at all. Providers 
based this observation on the majority of their patients being middle to upper class. This 
corresponds with the literature, as Jain and Hornstein (2005) found patients using fertility 
services had higher incomes. Financial costs are one of the biggest challenges facing 
infertile people in NL. 
 6.4.1.2 Opportunity.  
Patients and service providers both discussed the loss of vacation time and sick 
leave for patients attending multiple appointments and traveling for care. They also 
described patients choosing to pay for treatment instead of going on trips or home 
renovations. Both groups noted the sacrifice of opportunities made by fertility patients. 
Redshaw et al. (2007) also reported the loss of vacation time for medical appointments 
and treatment among fertility patients in the UK. Mathews, Buehler, and West (2009) 
discussed the loss of sick leave that cancer patients face for their treatment, however it 
was mentioned in the context of income loss and financial costs, rather than an 
opportunity cost. Although lost opportunities might not be the most obvious cost of using 
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fertility services, they have a large impact on a patient’s experience with infertility and 
fertility care. Future research should examine the multitude of opportunity costs patients 
undertake when availing of fertility treatment. 
 6.4.1.3 Emotional.  
The emotional costs of infertility and fertility treatment were described somewhat 
differently by patients and service providers. Even though the emotional costs were not 
directly explored with patients, they mentioned feeling depressed, disappointed, and 
stressed. Providers noted that patients experienced grief, desperation, isolation, injustice, 
and stigma. The sadness, disappointment, and stress that patients felt were described 
similarly by service providers. However, service providers discussed the emotional 
aspects of fertility treatment more objectively, addressing many more areas. This may be 
in part due to the patients who came forward, as there would be participant selection bias; 
that is, patient participants had likely overcome difficulties related to social stigma and 
therefore did not report this as a challenge. Additionally, service providers were more 
likely to discuss the desperate acts of patients, like triggering ovulation after being 
advised against doing so, because patients would not want to report a socially undesirable 
response.  
These emotional costs, including stress and disappointment (McDowell & 
Murray, 2011; Redshaw et al., 2007), are largely supported in the literature. Domar and 
Gordon (2011) surveyed couples that had difficulty getting pregnant to determine the 
emotional impact of infertility. They found that women who received hormone injections 
often reported being upset about failed treatment and having anxiety throughout their 
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treatment, demonstrating the impact fertility drugs have on patient emotional well-being. 
Women also mentioned feeling flawed as a result of their inability to conceive. Many 
respondents disclosed that they often felt frustrated and impatient and that they hid their 
diagnosis from family and friends. Holley et al. (2015) found that of 174 women being 
treated for infertility, 39% of them had major depressive disorders. Infertility and 
undergoing fertility treatment is a highly emotional experience, as shown by patients, 
providers, and the literature. 
6.4.2 Geography.  
Patients travelling from farther than 50 km away had geographical challenges that 
exacerbated the financial burden associated with treatment. At times these patients would 
face greater costs because they were more likely to leave the province for IVF, especially 
if they were from the west coast of Newfoundland. Patients from the west coast would be 
more likely to leave the province for IVF treatment because the distance and cost of 
travelling out-of-province would be comparable to travelling to St. John’s for treatment. 
However, patients from around St. John’s (living within 50 km of the fertility clinic) who 
left the province for IVF would face similar financial challenges to those using IVF from 
other areas of the province.  
Previous studies have corroborated these results and found that income (Jain & 
Hornstein, 2005), factors impacting cost (e.g., travelling for treatment) and geography 
(Mathews, West, & Buehler, 2009; Redshaw et al., 2007) prevent access to a variety of 
health services. Rural residents, those without insurance, and those with low income 
reported that the costs associated with treatment and travel were more likely to impact 
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treatment decisions (Mathews, West, & Buehler, 2009). Living outside of St. John’s and 
surrounding areas created challenges for fertility patients in NL, as they were forced to 
travel great distances for treatment and take on additional costs. The unique challenges 
that geography presents for fertility care in NL are largely determined by the nature of 
these services, which is further discussed in section 6.4.4. 
6.4.3 Lack of service availability.  
The lack of IVF related services available in NL posed a great challenge for 
patients, especially because of the isolation of the province. Women in the UK who 
sought infertility care reported having difficulty availing of services due the lack of 
locally available treatment and the costs associated with travelling for treatment 
(Redshaw et al., 2007). In a Canadian study looking at rural parturient women in British 
Colombia, the women reported geographic isolation, inavailability of local health 
services, and cost of travelling to give birth as challenges and realities that they face 
when they are pregnant and about to deliver (Kornelsen & Grzybowski, 2006). These 
challenges are similar to those described by participants in this study, as patients had to 
leave a geographically isolated province to access IVF services. 
6.4.4 Nature of services.  
The nature of fertility services makes availing of treatment more difficult for NL 
fertility patients than for many other patients in the province because patients must be 
treated at NLFS in St. John’s. Unlike the perinatal program, which does travelling clinics, 
fertility services are not portable and patients must travel to the clinic for treatment. Even 
though NLFS uses teleconsultations for history-taking appointments, patients must come 
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in to St. John’s for their actual treatment. In contrast, psychiatry can manage all 
treatments through telemedicine appointments (Elford et al., 2001). Additionally, 
alternative providers close to home cannot be used, as they are for follow-up care for 
oncology (Mathews, Buehler, & West, 2009), because fertility service providers are 
highly trained to provide this sub-specialized treatment. Finally, fertility treatment must 
be carefully managed and timed in order to maximize the chances for conception, which 
creates further challenges for patients, as treatment cycles are easily compromised. 
According to patients and providers, these factors often made accessing services 
challenging for patients and contributed to treatment costs. 
6.4.5 Physical environment. 
Participants in both studies mentioned the physical environment, specifically the 
winter weather, as a barrier to accessing fertility treatment. Patients would have to come 
into St. John’s early and take on additional costs for accommodations if a snowstorm was 
forecast, so that they would not compromise their treatment and be able to complete their 
treatment cycle. The weather creating challenges for patients has been reported by cancer 
patients in northern Ontario (Lightfoot et al., 2005). 
6.4.6 Partner separation.  
Partner separation was another barrier described by patients and providers. 
However, providers discussed this more frequently because of their experience with a 
variety of patients and circumstances. In NL, it is not uncommon for partners to work 
out-of-province, most commonly in the oil sands of Alberta or offshore oil drilling, due to 
high unemployment rates in the province (Schmidt, 2014). Patients and providers often 
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tried to alter treatment in order to compensate for partner separation, which increased the 
financial costs associated with treatment and could have contributed to failed or cancelled 
treatment cycles and ensuing stress. 
6.4.7 Social stigma.  
The social stigma associated with infertility and using fertility services was 
primarily discussed by service providers. This was likely a result of providers being able 
to draw from their knowledge of many patient experiences and patients who felt 
stigmatized being less likely to come forward for an interview. The stigma associated 
with infertility and the stress this stigma causes is well documented in the literature 
(Whiteford & Gonzalez, 1995). Stigma has been proven to increase fertility-related 
distress and patient perceptions of low social support, which increases overall stress 
(Slade, O'Neill, Simpson, & Lashen, 2007). While social stigma may not be an obvious 
challenge that patients encounter (like financial costs), it contributes heavily to the 
emotional costs of accessing fertility treatment. 
6.5 Impact on Treatment 
Patients and service providers both described the impacts of barriers on treatment 
for heterosexual women (in couples) looking to conceive. As we expected, both patients 
and providers reported that patients’ financial and geographic situations affected 
treatment decisions, and therefore the impacts on treatment can be separated into patient 
and provider-driven responses.  
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6.5.1 Patient driven responses.  
A patient driven response results from a specific barrier that a patient has 
encountered, and is something that the patient has the ability to control with regard to 
their treatment. Patients often reported barriers affecting where they chose to undergo 
treatment, for how long they chose to be treated, and the type of treatment they used.  
Patients and service providers differed slightly in their identification of patient-driven 
responses to treatment barriers. Both groups mentioned that patients would stop treatment 
due to financial and emotional challenges. Additionally, patients would substitute IUI for 
IVF or avoid IVF when they could not afford the treatment. Patients noted that financial 
challenges impacted their decision on the location of their treatment, limited family size, 
and some patients said that the financial challenges had no impact on their treatment 
decisions. Service providers reported that patients would choose cheaper (and sometimes 
less effective) drugs, delay using IVF, and opt to transfer multiple embryos.  
Financial and emotional costs causing patients to end treatment was also found in 
the infertility literature. Patients reported exhausting financial resources and enduring 
high levels of emotional stress, which lead to their decision to end their treatment (Akyuz 
& Sever, 2009; McDowell and Murray, 2011). Some of these patient impacts on 
treatment decisions were corroborated by a NL study on cancer care (Mathews, Buehler, 
& West, 2009). Service providers reported that cancer patients will substitute or ration 
medications, choose radical treatments, lengthen the time between follow-up 
appointments, and choose inpatient care (Mathews, Buehler, & West, 2009) to ease 
financial burden. Fertility patients choosing cheaper drugs and opting to transfer multiple 
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embryos may be seen as comparable to cancer patients substituting/rationing medications 
and choosing radical treatments, respectively.  
Even though patients may make the final decisions on their treatment, oftentimes 
they make these decisions with the help of service providers. The service providers also 
work to make treatment more affordable and geographically close to patients when 
possible. 
6.5.2 Provider driven responses.  
A provider driven response results from the same barriers as the patient driven 
response, however it is an aspect of patient care that the provider has the ability to control 
to make treatment more accessible to their patients. Providers noted that they would try to 
alter care systematically when possible; for example, by making certain aspects of care 
closer for patients from rural areas and changing drug protocols. Although patients and 
providers have power over different aspects of the treatment process, oftentimes when it 
comes to making treatment decisions both groups make these decisions together. 
Provider-driven responses were mainly identified by service providers, although patients 
did note some treatment decisions that were strongly influenced by providers. Patients 
and providers mentioned that providers would encourage patients to use IUI before IVF 
and allow them to continue using IUI beyond the recommended number of cycles. 
Providers also reported that they changed drug protocols, manipulated ovulation to time 
fertile periods, used teleconsultations, and minimized patient clinic visits. Technology 
was used as an alternative to face-to-face care, as seen by the use of teleconsultations, 
when necessary and if possible. In Newfoundland, telemedicine has been useful in 
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reducing medical-related travel costs, especially for specialized services (Elford et al., 
2001). For example, telepsychiatry was found to have high patient satisfaction and to be 
useful in reducing costs resulting from travel (Elford et al., 2001). However, in this study, 
telemedicine could not entirely replace the need for in person care during the fertility care 
process, as it has done for psychiatry. 
These provider-driven responses are somewhat similar to those found in the 
Mathews, Buehler, and West (2009) study on cancer care in NL. Providers tried to help 
cancer patients minimize out-of-pocket costs by changing drug prescriptions, admitting 
patients to hospital, shortening radiation treatments, arranging follow-up appointments 
close to home, and changing appointment schedules. The provider-driven responses 
described here overlap with our study, as both included changing prescriptions and 
adapting appointments (by minimizing visits to the clinic and using teleconsultations in 
this study). We were not able to find any similar studies that were IVF focused. 
The patient and provider reported impacts vary as one would expect based on 
perspective and what the groups perceive to control. Providers focused on how services 
are delivered, while patients discussed the logistics surrounding treatment. Providers 
were also more likely to mention aspects that patients may have been uncomfortable 
discussing, such as choosing cheaper drugs and opting to transfer multiple embryos. As 
previously noted, many of the treatment decisions are made together and the patient and 
provider-driven responses overlap heavily. 
The quality of patient care, and at times patient safety, when patients neglected to 
follow provider recommendations, was compromised as a result of the barriers patients 
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encountered. Overall, the barriers to treatment and their impact on treatment decisions 
were found to affect patient care. 
6.6 Mitigation Strategies for Financial Costs 
As a result of financial barriers, patients would look for a variety of ways to help 
fund their fertility treatments.  
6.6.1 Methods of payment and facilitators to treatment.  
Patients and service providers cited many of the same methods of payment for 
treatment and travel. These include out-of-pocket methods like credit card and lines-of-
credit, funds from family and friends, and private insurance. There is little in the 
literature about methods of payment, however few patients reported having family 
members offer to help them pay for fertility treatment (Domar & Gordon, 2011) and 
many cited out-of-pocket payments (Wu, Odisho, Washington, Katz, & Smith, 2014). 
Facilitators to accessing treatment were more heavily focused on by patients, 
however were also mentioned by service providers. Patients noted that affording 
treatment was made easier by proximity to services, wealth, MCP coverage, low lab fees, 
claiming their treatment and travel on their income tax, and family and friend monetary 
and in kind contributions. Service providers also mentioned patient wealth, MCP 
coverage, claiming treatment on income tax, and family and friend contributions as 
factors that made it easier for patients to avail of treatment. A few of these facilitators 
were corroborated by the literature, including family contributions (Domar & Gordon, 
2011) and wealth (Jain & Hornstein, 2005). 
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 These facilitators largely focus on financial aspects and do not consider other 
barriers. This is likely because of how the interview questions were posed and the study 
being framed around costs. Future studies could look to identify ways to address other 
non-cost related facilitators to fertility treatment in order to potentially improve patient 
experiences.  
6.6.2 Knowledge and information about costs.  
Many patients would look to blogs and clinic websites for information about cost 
and rarely received information about cost directly from their service provider. There was 
a lack of understanding among patients and providers about what is covered and not 
covered by MCP and private insurances. This could impact patient treatment decisions, as 
patient comprehension of information has been shown to improve compliance with 
provider recommendations and treatment outcomes (Simpson et al., 1991). 
 The literature largely supports these findings of under-informed patients, as 
multiple studies have demonstrated poor patient education in fertility care. Patient-
centredness, including the quality of information that patients receive about their fertility 
treatment (van Empel et al., 2010), has been largely overlooked (van Empel, Nelen, 
Hermens, & Kremer, 2008). Additionally, Mourad et al. (2009) found that Dutch fertility 
patients believed information provision to be an important part of their care. However, 
many were not properly informed according to national standards and did not receive 
enough information about their diagnosis, causes of their condition, and the risks 
associated with treatment. Patient education specifically related to fertility treatment costs 
seems to be an area that is overlooked in the literature. Future studies should explore 
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patient knowledge surrounding treatment cost, insurance coverage, and financial 
assistance to improve information provision for fertility patients.  
Based on these findings, NLFS should consider hiring an employee, such as a 
social worker, who is specifically trained to have conversations and provide direction 
about cost, MCP and private insurance coverage, and financial assistance opportunities. 
More thorough discussions could help patients with making informed decisions. Given 
the significant costs associated with accessing fertility care, NLFS should provide more 
information about managing costs. 
6.7 The Right to Reproduce and Injustice 
Both fertility patients and service providers consider fertility services to be 
medically necessary, which is the basis for their perspectives. They believe that not 
having public insurance coverage for these services is a form of inequality. There was a 
lot of discussion in the interviews about fairness and the right to reproduce. Service 
providers and patients claimed that being able to have biological children was an innate 
right and infertility treatment should be considered medically necessary in NL.  
This perceived injustice can be linked to critical theory. Critical theory examines 
the relationship between political, economic, social, and cultural factors to gain insight 
into the reasons for inequality (Buchanan, 2010). This is relevant to fertility service 
access because policy-makers, government, and physicians decide what services MCP 
covers as per the Canada Health Act. These groups have power and are making decisions 
for the general population, often not considering the needs of specific or minority 
populations. This introduces a power dynamic and oppresses patients using fertility 
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services. 
The patients’ and providers’ beliefs that there is a right to reproduce and that 
fertility services should be deemed medically necessary are likely influenced, to some 
extent, by social constructs, such as motherhood and biological parenting. As previously 
discussed, women often feel social pressure to be mothers (Staikou, 2014) and experience 
greater stress than men from infertility (Newton et al., 1999). Furthering this point, there 
is often pressure to be a biological parent, as society defines parenthood in terms of 
biology. These social constructs create ideas among patients and providers about what is 
fair and what is a right based on what is socially “normal”. 
Taking all of this into account, it should be acknowledged that how infertility is 
defined frames what policy options are considered. Defining infertility as a disease 
creates a stronger argument to include fertility treatment as medically necessary under the 
Canada Health Act (Picard, 2011). However, those who believe Medicare (or more 
specifically in NL, MCP) should cover fertility services are generally those who will 
benefit from this coverage. Providers benefit from expanding the number of billable 
services and patients benefit from not having to pay out-of-pocket for the 
service. However, where provinces (e.g., Ontario and Québec) have insured fertility 
treatments, they have used public insurance as a means to regulate services, by specifying 
the conditions under which billing Medicare is allowed, for example by limiting the 
number of embryos that can be transferred, establishing age limits for eligibility, or 
limiting number of insurable IVF attempts (Picard, 2011).  
The lack of comprehensive public health insurance coverage for fertility services, 
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particularly in NL, creates access inequality in the provincial health care system. Policy-
makers and others at the forefront of change for social justice issues should begin to 
reconsider what they believe to be “medically necessary”.  
6.8 Strengths 
 6.8.1 Study design.  
This project had many strengths. We began by pretesting the interview questions 
to ensure that the questions were posed in the best way possible and by training the 
interviewer to ensure professionalism (Berg, 1995). We described the methods in detail to 
make the study transferable (Cope, 2014; Green & Thorogood, 2009). We also used 
triangulation within the study by interviewing both patients and service providers and 
with the literature by comparing study results to the literature. The similarities between 
patient and service provider interviews, specifically in terms of the challenges patients 
face when accessing fertility services and how these challenges impact treatment 
decisions, add credibility to the results of this research.   
6.8.2 Data collection and analysis.  
All patient interviews were done by phone and all provider interviews were done 
in person, while both groups were given the choice on interview method, the uniformity 
within each group makes each study internally consistent. The patient and provider 
studies were treated independently with their own interview guides, coding templates, 
and results. Additionally, all interviews were recorded, transcribed, and coded 
independently to maximize dependability and confirmability (Cope, 2014; Green & 
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Thorogood, 2009). Furthermore, we reported negative cases, such as patients not 
perceiving cost as a barrier, to maximize credibility (Cope, 2014). 
This project combines information from first hand patient experiences with 
perspectives of providers who were able to draw from a range of patient experiences. 
Finally, this project identifies areas for future research and is the first of its kind in NL, 
which is a unique case. 
6.9 Weaknesses 
6.9.1 Recruitment.  
There were also weaknesses to this research. First, there was a limited time frame 
for recruitment, which impacted the number of interviews we were able to conduct. The 
majority of recruiting of patient participants was done through Facebook, which means 
that many of the people targeted by recruitment were regular Internet and social media 
users. Posters were put up in NLFS late in the recruitment period, which meant that few 
responses could have been a result of the posters. Also, patients who chose to participate 
were more open about their infertility and often not actively seeking treatment, possibly 
because those who were undergoing treatment were faced with too much emotional stress 
to participate.  
Furthermore, we had a limited sampling population. Patient participants were only 
from Newfoundland and none were from Labrador. Also, despite efforts to recruit more 
broadly only three patients were from rural areas of Newfoundland and the remaining 
eight patients lived within 50 km of the fertility clinic. In the future, studies should try to 
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have a more comprehensive sample, including more patients from rural and remote 
regions of the province. 
6.9.2 Data collection.  
Recall bias may have been an issue because participants may not remember an 
event or details exactly how they happened (El-Masri, 2013). As time passes, memories 
can change and be influenced by external factors. Oftentimes, people better remember 
significant life events. In this case, those who had a more difficult experience with 
fertility services may have remembered more than those who got pregnant more quickly 
or with less treatment.  
Bias responses to interview questions may have affected the data, as participants 
would look to provide responses to questions that they expect to be socially acceptable 
(Furnham, 1986), such as not disclosing that they may not have followed service provider 
health or treatment recommendations. Patients and providers also tried at times to direct 
the research and interview with their responses, which meant that interview questions 
were not answered as well as they could have been. 
 It was also clear through the interviewing process that patients were interested in 
discussing the emotional costs of fertility treatment and service providers often 
mentioned the resilience of their patients. However, exploring these ideas was beyond the 
scope of this project. Future studies should look at the emotional impact of infertility and 
patient resilience throughout their journey. 
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 Finally, it is important to note that these study results may not be transferable to 
populations or health systems outside of NL due to the unique health care system in the 
province. 
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7.0 Conclusion 
This project explored the barriers that residents of NL face when accessing 
fertility services and how these barriers impact treatment decisions. Eleven interviews 
were conducted with female fertility patients from across Newfoundland and eight 
interviews were conducted with service providers from NLFS to gather the perspectives 
of both patients and providers.  
Based on this research, we developed a conceptual framework. The framework 
considers patient group, therapeutic goal, and barriers when determining how treatment is 
impacted. This project in particular explored the barriers that heterosexual women (in 
couples) looking to have a baby experienced when accessing fertility services from the 
viewpoints of female patients and service providers and how all of these factors impacted 
treatment. The framework can be used to conceptualize and conduct studies to examine 
how alternate patient groups with different therapeutic goals experience barriers and their 
impact on treatment. 
For heterosexual women (in couples) seeking to become pregnant, the most 
frequently described barriers were costs, including financial, opportunity, and emotional, 
geography, lack of service availability, the nature of services, partner separation, and 
social stigma. Both patient and provider-driven responses to barriers were reported to 
have impacts on treatment decisions. Patient-driven responses included delaying IVF, 
substituting IUI for IVF, choosing a specific location for treatment, stopping treatment, 
choosing cheaper drugs, and opting to transfer multiple embryos. Provider-driven 
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responses included changing drug protocols, minimizing clinic visits, using 
teleconsultations, and manipulating ovulation. 
Although health and social service access issues are common for rural residents 
(Fuchsia Howard et al., 2014; Kornelsen & Grzybowski, 2006), fertility services present 
a unique set of challenges for NL residents. Many specialized and sub-specialized 
services can be made more accessible to patients through technology (e.g., teleneurology, 
telepsychiatry, etc.), alternative providers (e.g., primary care, follow-up care for 
oncology, etc.), or visiting clinics (e.g., perinatal program, oncology, etc.). However, 
fertility services require that patients be treated in-person; only initial history counseling 
and blood work can be done by distance. Fertility service requires the expertise of sub-
specialists to provide treatment. The lab equipment is not portable, making mobile units 
unviable. Finally, there is a limited, individualized, and somewhat unpredictable period 
when conception can occur, ova can be harvested or embryos can be transferred. Even 
small delays can render a cycle of treatment useless, especially given the unavailability of 
gamete preservation services in NL. As a result, and unlike most other types of care, 
fertility services require that patients attend in person, in an urban center, and be available 
on multiple and often unpredictable visits over the course of their treatment. 
In addition to resources to pay for financial costs, information and knowledge 
were important facilitators to accessing fertility services. However, few patients were 
well informed on factors influencing the cost of treatment. MCP coverage was also a key 
financial facilitator for patients and was framed as a social justice issue by patients and 
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providers, who believed that these services should be more comprehensively covered 
under the provincial health plan. 
The following recommendations could help to make fertility services more 
accessible to NL residents. The clinic should consider hiring an employee, such as a 
social worker, who is specifically trained to have conversations and provide information 
about cost, MCP and private insurance coverage, and financial assistance opportunities. 
This could help patients make more informed decisions about treatment and help them to 
better manage their finances throughout treatment.  
Based on the current provincial economic situation, it is unlikely that IVF services 
will be available in NL for a long time, unless they are privatized. With that being said, 
travel subsidies should be put in place by the government to make travelling out-of-
province for treatment more affordable for NL residents. These subsidies must be 
actively promoted by the Department of Health and Community Services and by NLFS to 
ensure that patients are aware that they are available. 
 In addition, NLFS is actively working to make services more accessible to rural 
and remote residents of the province, through teleconsultations and by doing some 
monitoring by distance. However, the clinic staff should advocate for travel subsidies 
available to patients travelling within the province to minimize costs for these patients.  
Finally, future research should examine infertility, prevalence, and fertility service 
uptake among the many patient groups identified in this study other than heterosexual 
women (in couples). This research will broaden the health and research communities’ 
ideas, definitions, and understanding of infertility.  
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Appendix I: Patient Demographic Questionnaire 
 
1. In what year were you born?  _________ 
 
 
2. How far do you live from Newfoundland and Labrador Fertility Services? __________ 
 
 
3. What is your current marital status?  
 
□ Married/living with partner 
□ Single - divorced/separated 
□ Single – never married 
□ Single - Widow 
 
 
4. Besides Medicare (MCP), do you have any other health insurance? 
 
□ Yes  
□ No  
 
 
5. Thinking of all the family members in your household, last year in which category was 
your ‘before tax’ household income?  Please include income from all sources such as 
wages, pensions, rent and employment insurance.   
 
□ Less than $20,000 
□ Between $20,000 and $39,999 
□ Between $40,000 and $59,999 
□ Between $60,000 and $79,999 
□ Between $80,000 and $99,999 
□ $100,000 and above  
 
 
 
 
 
  
 119 
Appendix II: Patients Interview Questions 
 
1. How did you come about using Newfoundland and Labrador Fertility Services? 
a. When did you start receiving treatment? From where? 
b. Were you actively trying to get pregnant? Was there anything special you 
were doing? 
 
2. What services did you consider? What services did you use? 
a. What treatment did you receive?  
b. When did you receive drugs? How often? 
c. How many rounds of treatment, etc.? 
 
3. What influenced what services you considered? 
a. cost,  
b. age,  
c. geography play a role? 
 
4. What types of costs did you incur? 
a. Did you access multiple services that increased your costs? 
b. Did you access multiple rounds of treatment that increased your costs? 
c. How did travel affect cost? 
d. Was financial assistance made available to you? 
e. Where did you get your information about cost? 
 
5. How did these costs affect your decision-making? How did costs and travel 
influence your care and decision-making? 
a. Were there certain services and courses of treatment unavailable to you 
because of  
i. Cost? 
ii. Travel? 
b. Were there certain services and courses of treatment that were more 
practical because of  
i. Cost?  
ii. Travel? 
 
6. Where are you now? Where will you go from here? 
a. Will you have any more children? 
b. Will you try to access services again?  
 
7. Is there anything else you would like to add? 
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Appendix III: Service Provider Interview Questions 
 
1. Tell me about yourself 
a. When did you start working at the clinic? 
b. How did you start working there? 
c. What services are offered? What services are not offered? What services 
are covered and what services are not covered? 
 
2. What are the common barriers that patients face when accessing fertility services? 
a. Where are patients travelling from when accessing services? Where to? 
b. Why must patients travel outside of the province for care? How often does 
this occur? 
c. In what ways does this travel impact costs?  
d. How do patients normally pay for the costs of treatment and travel (private 
insurance or out-of-pocket)? What is your knowledge around private 
insurance and what it does and doesn’t cover for patients? 
 
3. How do these barriers affect the delivery of fertility services and treatment? 
a. What is the procedure for managing the care of a patient travelling from 
outside the St. John’s area compared to someone travelling from within 
the region? 
b. How do costs (travel and otherwise) affect treatment plans? What is the 
procedure for managing the care of a patient who does not have the 
financial means to be treated? Are certain treatments impractical? 
 
4. What assistance is available to people struggling to access fertility care?  
a. What forms of financial assistance, either provided by the provincial 
government or another organization, are available? 
b. What support services are available?  
 
5. Is there anything else you would like to add? 
 
